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I. INTRODUCTION
Since 1980 corporate takeover transactions have increased dramati-
cally in size and volume.' Along with the rise in acquisition activity has
1. See SENATE COMM. ON BANKING, HOUSING, AND URBAN AFFAIRS, TENDER OFFER DISCLOSURE
AND FAIRNESS ACT OF 1987, S. REP. No. 265, 100th Cong., 1st Sess. 9 [hereinafter Tender Offer Act].
Between 1981 and 1986 the number of merger transactions nearly doubled from 2,326 to 4,084.
The reported value of the transactions nearly tripled during the same time. Transactions over $1
billion grew four times in number, representing over 34% of the total merger and acquisition value
in 1986. In 1986 there were 29 transactions in excess of $1 billion. Id.; see Dobrzynski, A New
Strain of Merger Mania, Bus. WK., Mar. 21, 1988, at 122, 122 (relating that even in light of the
October 1987 crash, corporations and individuals proposed $50 billion worth of acquisitions in the
first two months of 1988); Jensen, Takeovers: Their Causes and Consequences, 2 J. EcON. PERSP.
21, 21 (1988) (stating that the value of transactions in the takeover market ran at a record rate of
about $180 billion per year in 1985 and 1986, 47% above the 1984 record of $122 billion); Weber &
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come a marked increase in the number of contested or hostile take-
overs.2 The proliferation of hostile bidss for corporate control' has
Baum, Takeovers Are Back, But Now the Frenzy is Gone, Bus. WK., Feb. 8, 1988, at 24, 24 (com-
menting that takeover activity reached a "frenzy" in 1986 and 1987 when approximately $380
billion worth of companies changed hands); see also Jarrell, Brickley & Netter, The Market for
Corporate Control: The Empirical Evidence Since 1980, 2 J. ECON. PERSP. 49, 49-50 (1988) (citing
COUNSEL OF ECONOMIC ADVISORS, ECONOMIC REPORT OF THE PRESIDENT 187-216 (1985)). The Coun-
cil of Economic Advisors indicated that in the period from 1981 to 1984, the average annual re-
ported real value of mergers and acquisitions was 48% greater than in any four year period from
the late 1960s to the early 1970s. In addition, 89 of the 100 largest takeover transactions recorded
through 1983 took place after 1979, and 65 occurred after 1982. Id. at 50. See generally 1 M.
LIPTON & E. STEINBERGER, TAKEOVERS & FREEZEOUTS § 1.01 (1987) (noting that "[s]ince the adop-
tion of the Williams Act in 1968, the popularity and acceptability of takeover or 'tender offer' bids
has grown"); Winter, Rosenbaum, Stumpf, Parker, State Takeover Statutes and Poison Pills, in 3
SHARK REPELLENTS AND GOLDEN PARACHUTES: A HANDBOOK FOR THE PRACTITIONER (1988) [hereinaf-
ter STATE TAKEOVER STATUTES].
2. Tender Offer Act, supra note 1, at 9. Although hostile or contested tender offers represent
a small fraction of all transactions (2.8%), they represent a large portion of the value of all mergers
and acquisitions (44.4%). Because hostile takeover battles often involve large companies with
thousands of shareholders and workers, the concern for use of abusive tactics in the takeover pro-
cess is high. Id.; see 1 AMERICAN LAW INSTITUTE-AMERICAN BAR ASSOCIATION COMM. ON CONTINU-
ING PROFESSIONAL EDUC., TAKEOVER DEFENSES AND DIRECTORS' LIABILITIES 3 (M. Lipton ed.
1986) [hereinafter 1 TAKEOVER DEFENSES] (noting the increase in the number, the scope, and the
intensity of takeover battles in recent years); Block & Miller, The Responsibilities and Obligations
of Corporate Directors in Takeover Contests, 11 SEc. REG. L.J. 44, 44 & n.1 (1983) (noting the
unprecedented increase in corporate takeovers); Concept Release on Takeovers and Contests for
Corporate Control, 18 Sec. Reg. & L. Rep. (BNA) No. 32, at 1187 (Aug. 8, 1986) [hereinafter
Concept Release]; see also Levine, Lykos & Chafetz, Application of the Federal Securities Laws
to Defensive Tactics in Control Contents, in TENDER OFFERS 193 (M. Steinberg ed. 1985). In the
Levine, Lykos, and Chafetz article the authors noted:
Contests for corporate control have become ever more frequent phenomena on the American
business scene. Waged with the intensity of military campaigns and the weaponry of seem-
ingly bottomless bankrolls, these battles determine the destinies of large and small corpora-
tions alike. Elaborate strategies and ingenious tactics have been developed both to facilitate
takeover attempts and to defend against them. Skirmishes are fought in company boar-
drooms, in shareholders' meetings, and with increasing regularity, in the courts.
Id. at 193 & n.1 (quoting Norlin Corp. v. Rooney Pace Inc., 744 F.2d 255, 258 (2d Cir. 1984)).
3. Campeau Corporation and Federated Department Stores recently concluded a hostile
takeover battle which included R. H. Macy & Company. For a discussion of the contest, see Bet-
ting the Store: Campeau at Last Gets Federated-Now Can He Make a Go of It?, Wall St. J.,
Apr. 4, 1988, at 1, col. 6.
4. The surge in takeover contests prompted the Securities and Exchange Commission (SEC)
and both houses of Congress to consider tender offer reform as early as 1983. To date, however, no
legislation has been enacted. For a full discussion of the ongoing debate and commentary on SEC
recommendations and on the recently proposed House (H.R. 2172) and Senate (S. 1322) bills, see
The Battle over Tender Offer Reform: From the States and the Courts to Congress, 20 Sec. Reg.
& L. Rep. (BNA) No. 2, at 60 (Jan. 15, 1988). To ensure that no amendment would be added to
the Senate Bill preempting state antitakeover laws, Senator William Proxmire, the author of S.
1322, agreed to delete a provision from the Bill that would have prohibited a target company from
adopting a poison pill during a tender offer. Id. at 70. For the full text of the Senate Bill and the
accompanying Report of the Committee on Banking, Housing, and Urban Affairs, see Tender Offer
Disclosure and Fairness Act of 1987, [CCH Special 1] Fed. Sec. L. Rep. (CCH) No. 1268, at 1-189.
See Leebron, Games Corporations Play: A Theory of Tender Offers, 61 N.Y.U. L. REV. 153, 154-59
& nn.6-18 (1986) (outlining the various views on tender offer regulation).
1989] SHAREHOLDER RIGHTS PLANS 175
brought about the development of new offensive5 and defensive take-
over tactics.6 One of the newest defensive devices is known as a "poison
pill," or shareholder rights plan.1 This device is designed to make the
target corporation (target) prohibitively expensive to an acquiring cor-
poration (acquiror) in the event of a hostile takeover or tender offer.'
Since the 1985 decision in Moran v. Household International, Inc.,9 in
which the Delaware Supreme Court upheld the adoption of a poison pill
defensive plan1° by the Household board of directors,1" several hundred
5. See M. LIPTON & E. STEINBERGER, supra note 1, §§ 1.06, 5.02(1) (explaining "bear hugs,"
"casual passes," and "Saturday night specials"); 1 TAKEOVER DEFENSES, supra note 2, at 4-20 (dis-
cussing such takeover techniques as "bust-up" or "boot-strap" takeovers, "proxy fights," "two-tier,
front-end loaded bids," and "two-price bids"); Lipton, Corporate Governance in the Age of Fi-
nance Corporatism, 136 U. PA. L. REV. 1, 15-26 (1987) [hereinafter Lipton, Corporate Governance]
(discussing techniques such as "creeping acquisitions," "sweeping the street," and "partial tender
offers").
6. See Steinberg, Some Thoughts on Regulation of Tender Offers, in TENDER OFFERS, supra
note 2, at 273, 273-75 (defining defenses such as "lock-ups," "golden parachutes," and "shark
repellants"); Empirical Research Project, Defensive Tactics to Hostile Tender Offers-An Exami-
nation of their Legitimacy and Effectiveness, 11 J. CORP. L. 651, 688-702 (1986) (discussing the
legality and validity of the various defensive tactics); see also Block & Miller, supra note 2, at 52-
66. See generally M. LIPTON & E. STEINBERGER, supra note 1, § 6.01-09.
7. See P. RICHTER, CORPORATE ANTI-TAKEOVER DEFENSES: THE POISON PILL DEFENSE (1987);
Dawson, Pence & Stone, Poison Pill Defensive Measures, 42 Bus. LAW. 423 (1987) (detailing the
various types of poison pill plans available); Helman & Junewicz, A Fresh Look at Poison Pills, 42
Bus. LAW. 771 (1987) (furnishing brief history of poison pill plans and factors to consider in the
evaluation of a poison pill plan); Herzel & Shepro, The Changing Fortunes of Takeover Defenses,
15 SEC. REG. L.J. 116 (1987) (reviewing recent developments in the areas of discriminatory self-
tender offers and poison pill defensive tactics); Note, Protecting Shareholders Against Partial and
Two-Tiered Takeovers: The "Poison Pill" Preferred, 97 HARV. L. REV. 1964 (1984) [hereinafter
Note, "Poison Pill" Preferred] (arguing that state courts using a "substantial business purpose"
test should determine the validity of poison pill preferred stock); Note, Recent Developments in
the Use of the Poison Pill Antitakeover Defense: Limiting the Business Judgment Rule, 31 ST.
Louis U.L.J. 1083 (1987) [hereinafter Note, Developments in the Use of the Poison Pill] (conclud-
ing that the Seventh Circuit's analysis in Dynamics Corp. of America v. CTS Corp., 794 F.2d 250
(7th Cir. 1986), should be utilized by other courts in their analysis of poison pill plans); Comment,
Share and Share Unalike: Judicial Response to Poison Pill Discrimination Among Shareholders
of the Same Class, 33 WAYNE L. REV. 1067 (1987) [hereinafter Comment, Poison Pill Discrimina-
tion] (discussing the judicial treatment of poison pills that discriminate among shareholders of the
same class or series); Note, Dynamics Corp. of America v. CTS Corp.: Posner's Plan for Poison
Pills, 1987 WIS. L. REV. 711 (focusing on the business judgment rule's application to poison pills).
See generally 1 A. FLEISCHER, TENDER OFFERS: DEFENSES, RESPONSES, AND PLANNING 54-94 (Supp.
1987); M. LIPTON & E. STEINBERGER, supra note 1, § 6.03[4]; 1 TAKEOVER DEFENSES, supra note 2,
at 95-122.
8. Dawson, Pence & Stone, supra note 7, at 423; Herzel & Shepro, supra note 7, at 121-22;
see also OFFICE OF THE CHIEF ECONOMIST, SECURITIES AND EXCHANGE COMM'N, THE EFFECTS OF
POISON PILLS ON THE WEALTH OF TARGET SHAREHOLDERS 6 (Oct. 23, 1986) [hereinafter POISON PILL
EFFECTS] (stating that "[i]f the pill is 'swallowed' it is designed to economically 'poison' the ac-
quiror"); OFFICE OF THE CHIEF ECONOMIST, SECURITIES AND EXCHANGE COMM'N, THE ECONOMICS OF
POISON PILLS (March 5, 1986) [hereinafter POISON PILL ECONOMICS]; New Guise for Poison Pills,
21 MERGERS & ACQUISITONS, July-Aug. 1986, at 21.
9. 500 A.2d 1346 (Del. 1985).
10. Id. at 1357 (upholding the adoption of the plan on the theory that it was a legitimate
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large public corporations have implemented their own versions of the
shareholder rights plan.12 Although more than 500 companies have
adopted poison pill plans, the device remains controversial. 3
Poison pill plans typically are enacted by a potential or actual tar-
get corporation's board of directors without shareholder approval1 ' and
are implemented through the issuance of a pro rata dividend of
"purchase rights"' 5 to stockholders. 6 Each right usually entitles the
holder to purchase a share of stock at a specified price.'7 The rights
generally may not be transferred separately from the underlying com-
mon stock and may not be exercised until the occurrence of a specified
"triggering event,"' 8 such as a tender offer or third-party acquisition of
a certain percentage of outstanding stock.' Upon occurrence of the
exercise of business judgment). Only 37 companies had poison pills in place as of the date of the
Moran decision. Concept Release, supra note 2, at 1189.
11. Household's board adopted the plan for the purpose of preventing future hostile ad-
vances. Moran, 500 A.2d at 1349.
12. Herzel & Shepro, supra note 7, at 121 (commenting that poison pills are now the primary
takeover defense of several large companies); Letter from Martin Lipton to clients of Wachtell,
Lipton, Rosen & Katz (July 14, 1987) [hereinafter Lipton Letter] (relating that over 400 of the
nation's largest companies had adopted shareholder purchase rights plans by mid-1987); see also
The Instant Recap Pill, 22 MERGERS & ACQUISITIONS, Sept.-Oct. 1987, at 22 (poison pills adopted
in the second quarter of 1987); New Looks for Old Pills, 22 MERGERS & ACQUISITIONS, Mar.-Apr.
1988, at 21 (naming companies implementing poison pills during the fourth quarter of 1987); Shel-
ter of a State Law, 22 MERGERS & ACQUISITIONS, Jan.-Feb. 1988, at 22 (listing 15 companies adopt-
ing pills in the third quarter of 1987 and relating that poison pills continued to be the most
popular antitakeover measure). The data indicates that rights plans are very popular with Fortune
500 Companies.
13. Richards, Brussard & Williams, Rights Plans Developments and Recent Litigation, Nat'l
L.J., May 23, 1988, at 28, col. 1.
14. See, e.g., CRTF Corp. v. Federated Dep't Stores, [1987-1988 Transfer Binder] Fed. Sec.
L. Rep. (CCH) 93,680, at 98,114 (S.D.N.Y. Mar. 18, 1988); see also 1 TAKEOVER DEFENSES, supra
note 2, at 97-98; Concept Release, supra note 2, at 1189. The board of directors of a company with
sufficiently authorized but unissued common stock can implement a poison pill plan without share-
holder approval. Likewise, a company without sufficient unissued common stock, but which pos-
sesses authorized and unissued blank check preferred stock, can achieve the same result by
distributing rights exercisable for a preferred stock that are formulated to be equivalent economi-
cally to the common stock. 1 TAKEOVER DEFENSES, supra note 2, at 97-98.
15. The rights generally have a fixed-term of existence, or exercise period that is determined
by the board of directors (e.g., 10 years). 1 TAKEOVER DEFENSES, supra note 2, at 97; Dawson,
Pence & Stone, supra note 7, at 426. The issuance of the rights is a nontaxable activity for both
shareholder and issuer. 1 A. FLEISCHER, supra note 7, at 64. Because the rights are "out of money,"
they do not dilute earnings per share or otherwise alter the company's capital structure. Id.
16. See 1 A. FLEISCHER, supra note 7, at 64; 1 TAKEOVER DEFENSES, supra note 2, at 97;
Dawson, Pence & Stone, supra note 7, at 423.
17. See infra notes 43-115 and accompanying text (describing what the various rights plans
entitle their holders to do upon issuance).
18. See, e.g., CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,118;
see also 1 A. FLEISCHER, supra note 7, at 64; Dawson, Pence & Stone, supra note 7, at 423.
19. See, e.g., CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,118.
The Federated plan could be triggered by: 1) the acquisition by a third person or group of 20% or
more of Federated's shares; 2) a tender offer that would result in the acquiring person's owning
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triggering event, the rights detach2 ° and become exercisable.2'
A poison pill plan may contain a convertible preferred stock provi-
sion, 2 a "flip-over" provision,23 a "flip-in" provision, 4 a "back-end" or
note purchase provision,25 or a voting provision.28 Most of these provi-
sions allow only nonacquiring shareholders to exercise their rights. By
threatening a severe dilution in the investment capital, equity, or voting
power of the bidder, the poison pill encourages the acquiror to negotiate
the terms of a takeover with the target's board of directors.2 The tar-
get's board also may encourage negotiation by reserving the option to
redeem the rights at a nominal cost 29 at some time prior to or within a
specified time following the occurrence of a triggering event.3 0
30% or more of Federated's shares; or 3) a determination by the directors that any person holding
more than 15% was "adverse." Id. See generally 1 A. FLEISCHER, supra note 7, at 64-65; Concept
Release, supra note 2, at 1189-90.
20. 1 TAKEOVER DEFENSES, supra note 2, at 98; Helman & Junewicz, supra note 7, at 772. In
the case of the Federated Plan, the occurrence of a triggering event resulted in the issuance of
separate rights certificates on a "distribution date." CRTF Corp., [1987-1988 Transfer Binder]
Fed. Sec. L. Rep. (CCH), at 98,118.
21. At this point, the rights may be traded separately. Helman & Junewicz, supra note 7, at
772. As of the date of distribution, the Federated poison pill plan entitled the holder to purchase a
share of Federated preferred stock at a disadvantageous price, thus discouraging the holder from
exercising the right in such manner. However, if the board decided not to redeem the rights, the
rights entitled each holder to purchase common stock of "Federated-that is the flip-in right-or
of the acquiring person-the flip-over right-with a value twice the exercise price of the right"
(e.g., $500 worth of stock for the price of $250). CRTF Corp., [1987-1988 Transfer Binder] Fed.
Sec. L. Rep. (CCH), at 98,118. The exercise price is intended to reflect the long-term value of the
company's stock. 1 A. FLEISCHER, supra note 7, at 64.
22. See infra notes 55-69 and accompanying text.
23. See infra notes 70-84 and accompanying text.
24. See infra notes 85-95 and accompanying text.
25. See infra notes 96-106 and accompanying text.
26. See infra notes 107-119 and accompanying text.
27. CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,118; Dawson,
Pence & Stone, supra note 7, at 423.
28. CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,120 (recogniz-
ing that a poison pill "provides the directors with a shield to fend off coercive offers and with a
gavel to run an auction"); Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., 506 A.2d 173, 182
(Del. 1986) (stating that the "directors' role changed from defenders of the corporate bastion to
auctioneers charged with getting the best price for the stockholders at a sale of the company"); see
also Herzel & Shepro, supra note 7, at 131; Oesterle, The Negotiation Model of Tender Offer
Defenses and the Delaware Supreme Court, 72 CORNELL L. REV. 117 (1986) (arguing that target
managers should be viewed primarily as negotiating agents for target shareholders); Note, Devel-
opments in the Use of the Poison Pill, supra note 7, at 1086.
29. CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,118. The Fed-
erated board could redeem the rights for five cents each. Id. Federated argued that its refusal to
redeem the rights prevented CRTF from utilizing coercive techniques such as a "street sweep" or a
"front-end loaded offer," which would have resulted in damage to shareholder welfare. Id. at
98,120; see also Oesterle, supra note 28, at 121 & n.19; Comment, Poison Pill Discrimination,
supra note 7, at 1069 & n.17.
30. CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,118; see also 1
A. FLEISCHER, supra note 7, at 65 (indicating that the extent to which the rights are redeemable
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This Note analyzes the theories that have been used by various
courts to evaluate the legal and economic validity of poison pills. Part
II describes the different types of shareholder rights plans that have
been utilized by corporations, detailing the objectives, the effects, and
the risks of the plans. Part III examines the validity of poison pill plans
under state corporate law, focusing on poison pill plans that disallow
acquiring shareholders to exercise their rights. Part IV considers the
capacity of a board of directors to issue poison pill plans under state
fiduciary law and discusses the factors that should be considered by a
board when issuing a shareholder rights plan. Finally, Part V concludes
that courts should give primacy to the effect of the plans on share-
holder wealth maximization, but should consider all relevant factors in
determining the validity of the plans under a modified business judg-
ment rule.
II. SHAREHOLDER RIGHTS PLANS
A. The Objectives
Most boards of directors have adopted poison pill plans3 ' in re-
sponse to the dramatic rise in highly leveraged"2 and speculative take-
overs33 during the 1980s.2 Poison pills are designed to provide a target
after a triggering event is dictated by strategic factors and legal judgment); 1 TAKEOVER DEFENSES,
supra note 2, at 99 (stating that the redemption feature "is designed to permit a negotiated merger
or a white knight transaction even after a hostile tender offer has been commenced").
31. Poison pill plans typically are adopted without the approval of the corporation's stock-
holders. See Concept Release, supra note 2, at 1189; Note, Internal Transfers of Control under
Poison Pill Preferred Issuances to Shareholders: Toward a Shareholder Approval Rule, 60 ST.
JOHN'S L. REV. 94 (1985).
32. The proliferation of "junk" bonds has increased takeovers because junk bonds can be
issued with very little equity backing. Junk bonds are typically high yielding, below investment
grade bonds or preferred stocks that frequently have variable rates of exchangeability options cou-
pled with detachable warrants or other equity "kickers." To counter the increased vulnerability of
corporations to takeovers, boards of directors have adopted defensive tactics such as poison pills.
See 1 TAKEOVER DEFENSES, supra note 2, at 4-8.
33. A number of states, including Indiana, have passed antitakeover statutes to deter the
speculative takeover bidder. See, e.g., HAW. REV. STAT. §§ 416-171 to 416-172 (1985); IND. CODE
ANN. §§ 23-1-42-1 to 23-1-42-11 (Burns Supp. 1988); Mo. ANN. STAT. § 351.407 (Vernon Supp.
1987); OHIO REV. CODE ANN. § 1701.83.1 (Anderson 1985 & Supp. 1986); Wis. STAT. ANN. § 180.25(9)
(West Supp. 1987); see also Act of July 22, 1987, ch. 3, § 2, 1987 Ariz. Legis. Serv. 32, 38-41 (West)
(to be codified at ARIM. REV. STAT. ANN. §§ 10-1211 to 10-1217); Act of July 21, 1987, ch. 272, 1987
Mass. Adv. Legis. Serv. 200 (Law. Co-op.) (to be codified at MASS. GEN. L. ch. 110D, §§ 1-8, ch.
110E, §§ 1-7); Act of June 25, 1987, ch. 1, § 24, 1987 Minn. Sess. Law Serv. 911, 928-35 (West) (to
be codified at MINN. STAT. ANN. § 302A.671). Delaware also recently adopted an antitakeover stat-
ute. For a copy of the text of the Delaware takeover bill, see Delaware Takeover Bill (HB396), As
Passed by the Legislature and Signed by the Governor, 20 Sec. Reg. & L. Rep. (BNA) No. 5, at
209-211 (Feb. 5, 1988).
Indiana's "control share acquisition" statute was upheld recently by the United States Su-
preme Court in CTS Corp. v. Dynamics Corp. of America, 481 U.S. 69 (1987). For a thorough
[Vol. 42:173
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corporation's board of directors with the negotiating power necessary to
respond to a variety of coercive or abusive acquisition techniques.35 In
particular, some poison pill provisions protect shareholders against par-
tial36 and front-end loaded, two-tiered bids3 7 by establishing a mecha-
nism8 which ensures that the shareholders of the target receive a "fair"
discussion and analysis of the CTS case, see Langevoort, The Supreme Court and the Politics of
Corporate Takeovers: A Comment on CTS Corp. v. Dynamics Corp. of America, 101 HARv. L. REV.
96 (1987) (criticizing the Court for failing to consider the difficult problems posed by takeover
regulation).
34. See supra notes 1-2 and accompanying text; see also Easterbrook & Fischel, Corporate
Control Transactions, 91 YALE L.J. 698, 727 (1982) (discussing the effects of partial and two-tier
tender offers on the control of a corporation); Lipton, Corporate Governance, supra note 5, at 3-11
(discussing the stages of corporate development in the U.S. and the role that institutional investors
and tax and accounting developments have played in causing the current takeover boom).
35. See supra note 5 and accompanying text; see also Finklestein, Antitakeover Protection
Against Two-Tier and Partial Tender Offers: The Validity of Fair Priced Mandatory Bid and
Flip-Over Provisions Under Delaware Law, 11 SEC. REG. L.J. 291 (1984) (noting the rise in partial
and two-tier tender offers and concluding that carefully drafted fair price, mandatory bid, and flip-
over provisions can be valid defenses to these takeover devices). Certain poison pill features are
more effective when adopted in advance of a takeover attempt (e.g., flip-over and flip-in provi-
sions), while others are more appropriate if enacted in response to a specific takeover attempt (e.g.,
note purchase and voting provisions).
36. A partial tender is an offer by an acquiror to purchase a controlling but less than 100%
interest in a target. Partial tender offers permit a bidder to commence takeover bids for larger
entities because a bidder only needs to obtain financing for the acquisition of the controlling inter-
est. See Cities Serv. Co. v. Mesa Petroleum Co., 541 F. Supp. 1220 (D. Del. 1982). Because a partial
tender offer allows an acquiror to obtain control of a target and engage in a squeeze-out merger or
in self-dealing, minority shareholders are under pressure to sell their shares to avoid being locked
into a dangerous position. See Martin Marietta Corp. v. Bendix Corp., 549 F. Supp. 623, 631 (D.
Md. 1982); Radol v. Thomas, 534 F. Supp. 1302, 1312 (S.D. Ohio 1982); see also Bebchuk, Toward
Undistorted Choice and Equal Treatment in Corporate Takeovers, 98 HARv. L. REv. 1695, 1710-13
(1985); Brudney & Chirelstein, Fair Shares in Corporate Mergers and Takeovers, 88 HARV. L. REV.
297, 337 (1974); Finklestein, supra note 35, at 293; Lipton, Corporate Governance, supra note 5, at
17-18; Lowenstein, Pruning Deadwood in Hostile Takeovers: A Proposal for Legislation, 83
COLUM. L. REv. 249, 307-08 (1983); Note, "Poison Pill" Preferred, supra note 7, at 1966.
37. In a front-end loaded, two-tiered offer the acquiror makes a cash tender offer for a con-
trolling interest in the target and, at the same time, announces the intention that upon gaining
control of the company, the target will be merged into itself at a lower second-tier price. The
difference in prices unfairly pressures target shareholders. The coercive nature of two-tiered tender
offers is recognized widely. See, e.g., Martin Marietta Corp., 549 F. Supp. at 630 (stating that "[i]f
the [tender] offer is in fact 'coercive,' it would only be because its two-tier structure is revealed");
Radol, 534 F. Supp. at 1312 (commenting that a two-tiered tender offer is inherently coercive); see
also Finklestein, supra note 35, at 293 (stating that two-tier tender offers "put pressure on share-
holders to tender their shares to avoid being frozen out for lesser consideration in the second-step
transaction" (footnote omitted)); Lipton, Corporate Governance, supra note 5, at 18-19 (observing
that "[t]he two-tiered tender offer . . . gives the raider a mechanism for forcing target sharehold-
ers to tender because the squeeze-out merger is an announced part of the deal"); Lowenstein,
supra note 36, at 308 (noting that "[t]he two-tier pricing structure was concededly intended. . . to
coerce shareholders into tendering at the first stage"); Note, "Poison Pill" Preferred, supra note 7,
at 1966 (observing that the two-tier tender offer "maximizes the coercion inherent in the tender
offer process").
38. Most plans are triggered either by the acquisition of a specified percentage (e.g., 20%) of
shares by one entity, or by a tender offer for a specified percentage (e.g., 30%) of shares. See
VANDERBILT LAW REVIEW [Vol. 42:173
price"9 for their stock.40 Directors also might implement a poison pill to
deter a "bootstrap" or "bust-up" acquisition4' and to preclude a large
shareholder from engaging in a self-dealing transaction.42 Most impor-
tantly, a poison pill may encourage a prospective raider to negotiate
with the target" and, thus, ensure an orderly auction of the target cor-
poration for a fair price.44
CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,118. Upon the occur-
rence of a triggering event, the economic aspects of the rights plans allow shareholders either to
redeem their rights for cash or securities, to purchase shares of stock in the acquiror or target at a
substantial discount, or to exchange their rights for stock with increased voting privileges. See
infra notes 45-119 and accompanying text.
39. In the case of a partial tender offer, a fair price is a price that is equal to or higher than
that paid in the partial offer. For a front-end loaded, two-tiered bid, it is a price for the second
step of the transaction that is equal to or higher than the price paid in the first step of the transac-
tion. See Dawson, Pence & Stone, supra note 7, at 425.
40. Poison pill plans with flip-over, note purchase, or convertible preferred stock provisions
deter front-end loaded, two-tiered takeovers. See infra notes 55-106 and accompanying text. Flip-
in provisions, as well as note purchase and convertible stock plans, deter partial tender offers. See
infra notes 55-69, 96-106 and accompanying text.
41. A bootstrap or bust-up bid is used by an acquiror which is interested in acquiring only
certain assets or businesses of a target. The acquiror, which may have limited financial resources,
will join with other parties interested in other assets of the target and make a joint bid with a view
towards dividing up the target after gaining control. See M. LiProN & E. STEINBERGER, supra note
1, § 104[8].
42. Examples of self-dealing include: reducing dividends; selling assets to affiliates on terms
less favorable than the target could have obtained in arm's length negotiations; increasing compen-
sation levels for the acquiror; and recapitalizing or reclassifying the target's stock to increase the
proportionate interest of the acquiror. See 1 TAKEOVER DEFENSES, supra note 2, at 99-100; Dawson,
Pence & Stone, supra note 7, at 428.
43. See Edelman v. Fruehauf Corp., 798 F.2d 882 (6th Cir. 1986); see also 1 TAKEOVER DE-
FENSES, supra note 2, at 100; Herzel & Shepro, supra note 7, at 131.
44. See CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,120; Rev-
lon, Inc. v. MacAndrews & Forbes Holdings, Inc., 506 A.2d 173, 182 (Del. 1986); see also Dawson,
Pence & Stone, supra note 7, at 425; Herzel & Shepro, supra note 7, at 129-31. A number of states
have enacted statutes functionally similar to the shareholder rights plan in that they inhibit sec-
ond-step mergers designed to give the raider control of the target's assets. These statutes prevent a
10% shareholder from effecting a business combination with a target for five years following the
10% acquisition, unless the combination is approved by the target's board prior to acquisition of
the 10% stake. See IND. CODE ANN. § 23-1-43-18 (West. Supp. 1987); Ky. REV. STAT. ANN. §
271A.397(3) (MichielBobbs-Merril Supp. 1986); Mo. ANN. STAT. § 351.459 (Vernon Supp. 1987);
N.J. STAT. ANN. § 14A:10A-4 (West Supp. 1987); N.Y. Bus. CORP. LAW § 912(17)(b) (McKinney
1986); see also Act of July 22, 1987, ch. 3, § 2, 1987 Ariz. Legis. Serv. 32, 44-44 (West) (to be
codified at ARiZ. REV. STAT. ANN. § 10-1221 to 10-1223); Act of June 25, 1987, ch. 1, § 25, 1987
Minn. Sess. Law Serv. 911, 936-45 (West) (to be codified at MINN. STAT. ANN. § 302A.673); Act of
Aug. 10, 1987, ch. 4, § 4, 1987 Wash. Legis. Serv. 10, 19-20 (West); Act of Sept. 17, 1987, 1987 Wis.
Laws 45 (to be codified at Wis. STAT. §§ 180.725 to 180.726 (setting time limit at three years rather
than five)).
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B. The Types
Five basic versions of poison pills45 have been introduced since the
early 1980s:' e (1) convertible preferred stock dividend plans; 47 (2) flip-
over plans;48 (3) flip-in plans;49 (4) back-end 50 or note purchase plans;51
and (5) voting plans.2 Corporations have used various combinations of
45. Very similar to poison pills, "poison" securities are becoming an increasingly popular
takeover defense. See Clemens, Creating Financial Perils for Hostile Acquirors, 22 MERGERS &
ACQUISITIONS, Nov.-Dec. 1987, at 27 (discussing "poison preferred" and "poison debt"); The Debt
Repellent, 22 MERGERS & AcQUIsrrIONs, Jul.-Aug. 1987, at 21-22 (noting companies implementing
poison put options).
46. Dawson, Pence & Stone, supra note 7, at 424. See generally 1 A- FLEISCHER, supra note 7,
at 54-92; 1 TAKEOVER DEFENSES, supra note 2, at 95-122; Veasey, Finklestein & Abrams, Selected
Tactics in Control Contests: Poison Pills, Lock-Ups, Stockholder Consents and Other Defenses;
Application of the Business Judgment Rule and Allocating the Burden of Proof, in 3 DYNAMICS OF
CORPORATE CONTROL III 77-96 (1986) [hereinafter Selected Tactics in Control Contests].
47. See 1 A. FLEISCHER, supra note 7, at 55-64; Note, "Poison Pill" Preferred, supra note 7,
at 1964-65 & nn.2-3. In Telvest, Inc. v. Olson, No. 5798 (Del. Ch. Mar. 8, 1979), the Delaware
Chancery Court enjoined an early attempt to issue poison pill preferred stock as a defensive de-
vice, holding that the directors lacked authority to issue a preferred stock that would deprive
common stockholders of their pre-existing right to approve mergers by a majority vote. Four years
later, in National Education Corp. v. Bell & Howell Co., No. 7278 (Del. Ch. Aug. 25, 1983), the
Delaware Chancery Court considered a more sophisticated pill and refused to enjoin its issuance.
See also 1 TAKEOVER DEFENSES, supra note 2, at 95-96; Selected Tactics in Control Contests,
supra note 46, at 87.
48. See 1 TAKEOVER DEFENSES, supra note 2, at 96-101; Dawson, Pence & Stone, supra note
7, at 426-28; Selected Tactics in Control Contests, supra note 46, at 83-85. In Moran the Delaware
Supreme Court upheld the validity of a flip-over pill. Id. at 1357; see also 1 A. Fleischer, supra
note 7, at 64-69; POISON PILL ECONOMICS, supra note 8, at 4-5.
49. See 1 A. FLEISCHER, supra note 7, at 71-92; Dawson, Pence & Stone, supra note 7, at 428;
Herzel & Shepro, supra note 7, at 121-29. Flip-in plans have met some opposition in the courts.
See Amalgamated Sugar Co. v. NL Indus., 644 F. Supp. 1229 (S.D.N.Y. 1986), aff'd, 825 F.2d 634
(2d Cir. 1987); R.D. Smith & Co. v. Preway, Inc., 644 F. Supp. 868 (W.D. Wis. 1986); Dynamics
Corp. of America v. CTS Corp., 637 F. Supp. 406 (N.D. IMI. 1986), af'd, 794 F.2d 250 (7th Cir.
1986). But see CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,122-23;
Gelco Corp. v. Coniston Partners, 652 F. Supp. 829 (D. Minn. 1986); Unocal Corp. v. Mesa Petro-
leum Co., 493 A.2d 946 (Del. 1985).
50. "Back-end" or "fair market rights plans" more commonly are referred to as note
purchase rights plans.
51. See 1 A. FLEISCHER, supra note 7, at 70-71; POISON PILL ECONOMICS, supra note 8, at 6; 1
TAKEOVER DEFENSES, supra note 2, at 101-02; Dawson, Pence & Stone, supra note 7, at 428-29;
Selected Tactics in Control Contests, supra note 46, at 87-89. Courts have enjoined the use of note
purchase plans in at least three cases. See Edelman, 798 F.2d at 882; Minstar Acquiring Corp. v.
AMF, Inc., 621 F. Supp. 1252 (S.D.N.Y. 1985); Revlon, 506 A.2d at 173.
52. See 1 A. FLEISCHER, supra note 7, at 61-64; POISON PILL ECONOMICS, supra note 8, at 7; 1
TAKEOVER DEFENSES, supra note 2, at 124-26; Dawson, Pence & Stone, supra note 7, at 430-31;
Selected Tactics in Control Contests, supra note 46, at 90-96. The courts and the SEC have given
super-voting provisions a cold reception. See Minstar, 621 F. Supp. at 1257-59 (declaring the plan
unlawful under New Jersey law); Unilever Acquisition Corp. v. Richardson-Vicks, Inc., 618 F.
Supp. 407, 409-10 (S.D.N.Y. 1985) (preferred stock unlawful under Delaware corporate law);
ASARCO Inc. v. M.R.H. Holmes A. Court, 611 F. Supp. 468 (D.N.J. 1985) (special voting rights
not permitted by the New Jersey Business Corporation Act); Packer v. Yampol, No. 18432 (Del.
Ch. April 8, 1986) (granting a preliminary injunction against a super-voting preferred stock on
VANDERBILT LAW REVIEW [Vol. 42:173
these different poison pill provisions in defending against hostile acqui-
sitions.53 The newest poison pill plans include both a flip-over and a
flip-in provision. 4
The convertible preferred stock dividend plan, or "poison pill pre-
ferred, 55 is the precursor of all poison pill plans.56 Issued as a pro rata
dividend to all holders of a target company's common stock,5 the pre-
ferred stock possesses special redemption and conversion privileges that
are designed to ensure that shareholders receive a fair price for their
shares 58 and to allow the holders to retain their interest in the target
following a takeover.5 9 At a specified time60 following a bidder's acquisi-
tion of control of the target company,61 the preferred holders are enti-
tled to redeem their shares for a "fair price" as determined by the
plan.62  Alternatively, in the event of a substantial stock acquisition6 3
followed by a second-step merger,64 the preferred stock of the target
can be exchanged for an equivalent amount of voting stock of the ac-
quiror e5 Consequently, these two provisions deter acquisition by either
fiduciary rather than statutory grounds).
53. See supra note 12 and accompanying text.
54. See, e.g., CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,118-
19; Dawson, Pence & Stone, supra note 7, at 428; New Looks for Old Pills, supra note 12, at 21;
Shelter of State Law, supra note 12, at 22; Lipton Letter, supra note 12, at 2-3.
55. See Note, "Poison Pill" Preferred, supra note 7, at 1964-65.
56. 1 TAKEOVER DEFENSES, supra note 2, at 95. This plan was used in 1982 and 1983 by
several target companies facing a tender offer or a stock accumulation to protect shareholders from
partial and front-end loaded, two-tier offers.
57. Selected Tactics in Control Contests, supra note 46, at 78.
58. 1 TAKEOVER DEFENSES, supra note 2, at 95.
59. Dawson, Pence & Stone, supra note 7, at 430; Note, "Poison Pill" Preferred, supra note
7, at 1968.
60. The specified period is typically 30 days. See Dawson, Pence & Stone, supra note 7, at
429.
61. A number of other triggering events may be specified in the plan, such as acquisition of
30% or more of the target's voting power.
62. The redemption privilege attached to the stock is designed to discourage the making of a
particular tender offer by giving the shareholders of the target the power to deplete substantially
the target company's assets. See Note, "Poison Pill" Preferred, supra note 7, at 1967. The redemp-
tion price is determined through a formula provided in the shareholder rights plan, which may
reflect the average price for the issuer's common stock over a specified period of time (e.g., the
previous 12 months) or the highest price paid by the bidder for a share of the targets stock.
Dawson, Pence & Stone, supra note 7, at 430. However, exercise of this redemption right may be
suspended for 120 days. Id.; 1 TAKEOVER DEFENSES, supra note 2, at 96.
63. Typically the acquisition of 30% or more of a company's outstanding stock is deemed
substantial. 1 TAKEOVER DEFENSES, supra note 2, at 96.
64. See supra notes 36-37 and accompanying text.
65. The conversion privilege discourages two-tiered tender offers by equalizing the prices of
the tiers. See Note, "Poison Pill" Preferred, supra note 7, at 1967; see also Dawson, Pence &
Stone, supra note 7, at 430. The conversion rights "flip-over," with the substitute preferred stock
being convertible into the common stock of the acquiror. The market value at time of conversion is
equal to not less than the highest price paid by the acquiror for shares of the target during the last
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depleting the target's assets,6 or diluting the value of acquiror's stock.6 7
Although few preferred stock dividend plans have been adopted since
1983,68 these plans form the theoretical basis for the newer pills.6 9
Flip-over plans became popular70 following the decision of the Del-
aware Supreme Court in Moran. The flip-over provision is designed to
encourage an acquiror to negotiate with the board of directors of the
target company71 rather than proceeding with a hostile acquisition.72
Under a flip-over plan corporations typically distribute to their com-
mon stockholders a pro rata dividend consisting of a right to purchase
stock. 73 Prior to the occurrence of a triggering event, the right is subject
to redemption by the board of directors74 and can neither be exercised
nor transferred separately.75 Once a triggering event such as the acqui-
twelve months. 1 TAKEOVER DEFENSES, supra note 2, at 96.
66. If a bidder acquires a significant ownership of the targets stock but no business combina-
tion is consummated, the targets assets are depleted by the payment to stockholders of the is-
suer's "fair value" through redemption of the preferred stock.
67. If a business combination is consummated, the acquiror's stock is diluted through the
conversion of the preferred stock of the target into the voting stock of the acquiror. The redemp-
tion and conversion options neutralize the coercive effects of partial and two-tier tender offers by
allowing the shareholders to decline to tender their shares yet still receive the tender offer price in
cash or its equivalent if the tender offer succeeds. Note, "Poison Pill" Preferred, supra note 7, at
1967.
68. See POISON PILL ECONOMICS, supra note 8, at 4. The three or four companies known to
have adopted these plans eventually were taken over, and no companies are reported to have
adopted any form of these plans since 1983. Id.
69. The redemption and conversion features show up in the subsequent plans and are analo-
gous to a "flip-in" and a "flip-over" plan respectively. See supra note 56 and accompanying text.
70. See supra notes 9-12 and accompanying text.
71. See 1 TAKEOVER DEFENSES, supra note 2, at 96; infra note 280 and accompanying text.
72. See 1 TAKEOVER DEFENSES, supra note 2, at 96; supra note 5 and accompanying text.
73. See 1 A. FLEISCHER, supra note 7, at 64; 1 TAKEOVER DEFENSES, supra note 2, at 97;
Dawson, Pence & Stone, supra note 7, at 426; Selected Tactics in Control Contests, supra note 44,
at 80. The duration, or exercise period, of the rights is a period of time (usually between three and
ten years) that is determined by the board. The board fixes the exercise price of the rights at a
figure that approximates the value of the stock at the end of the exercise period (a figure that is
typically two or more times the current market value of the stock). Because the exercise price is
"out of money," the rights do not dilute the company's earnings per share when they are issued
and may not have any negative impact on the market price of the company's common stock. See
sources cited supra.
74. Typically, the rights are redeemable by the board of directors for a nominal price prior
to, or within a short time following, the occurrence of a triggering event. Dawson, Pence & Stone,
supra note 7, at 426. This feature is designed to permit a negotiated merger or a white knight
transaction even after a hostile tender offer has been commenced. 1 TAKEOVER DEFENSES, supra
note 2, at 99.
75. CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,118. Initially,
the rights are transferrable only with the common stock and are not exercisable. Id. Under the
Federated plan, as of the distribution date a holder of a right could buy a share of Federated
preferred stock at a "very disadvantageous price." Id. This feature discouraged the shareholder
from using the right to purchase preferred stock. This Federated stock could be redeemed by the
board at a price of 5 cents each. Id.
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sition of a specified amount of the company's stock by one entity 6 or
the commencement of a tender offer 77 occurs,78 however, the issuer dis-
tributes certificates evidencing the rights to the shareholders. 9 At that
time, the rights become exercisable, tradable, 80 and sometimes nonre-
deemable8 1 If the acquiror triggers the plan and then proceeds with a
merger or similar business combination transaction,"2 the flip-over pro-
vision entitles each rights holder to purchase the acquiror's common
stock at a substantial discount.83 Because the flip-over provision does
not operate unless the bidder attempts to acquire all the target com-
pany's common stock by a merger or by some other type of business
combination, flip-over pills do not prevent all-cash tender offers for all
of the target's shares, or open-market purchases of a controlling interest
in the target. 4
To fill this gap, corporations have added flip-in provisions to their
flip-over plans.85 Flip-in provisions enable common stockholders other
than the acquiror s8 to purchase shares of stock of the target company at
a bargain price87 following certain self-dealing transactions88 or trigger-
76. The threshold under the Federated rights plan was 20% of the company's stock. Id. see
also Dawson, Pence & Stone, supra note 7, at 426.
77. Under the Federated Plan, the commencement of a tender offer for 30% of the com-
pany's stock was viewed as a triggering event. CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec.
L. Rep. (CCH), at 98,118.
78. The Federated plan also regarded the acquisition of 15% of the company's stock by an
adverse person as a triggering event. Id.
79. Ten business days after the occurrence of one of the triggering events, separate rights
certificates were to be issued under the Federated plan. Id.; see also Dawson, Pence & Stone,
supra note 7, at 427.
80. Dawson, Pence & Stone, supra note 7, at 427, Selected Tactics in Control Contests,
supra note 46, at 80.
81. Dawson, Pence & Stone, supra note 7, at 427; Selected Tactics in Control Contests,
supra note 46, at 81. But see CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH),
at 98,118 (Federated rights could be redeemed even after the triggering event).
82. 1 A. FLEISCHER, supra note 7, at 65; 1 TAKEOVER DEFENSES, supra note 2, at 98.
83. The Federated flip-over provision entitled the rights holder to purchase common stock of
the acquiror with a value two times the exercise price of the right (i.e. $500 worth of stock for an
exercise price of $250, a 50% discount). CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L.
Rep. (CCH), at 98,118; see also 1 TAKEOVER DEFENSES, supra note 2, at 99; Dawson, Pence &
Stone, supra note 7, at 427. Because the extent of the dilution of stock depends on the number of
rights outstanding prior to the merger or other business combination, the potential dilution result-
ing from the right to purchase the acquiror's stock at half price is obvious.
84. See 1 A. FLEISCHER, supra note 7, at 69; 1 TAKEOVER DEFENSES, supra note 2, at 97;
Herzel & Shepro, supra note 7, at 122. Sir James Goldsmith used a creeping acquisition strategy to
avoid the flip-over rights and to take control of Crown Zellerbach. Goldsmith acquired over 50% of
Crown Zellerbach's shares on the open market and took control of the board of directors. PoIsoN
PILL ECONOMICS, supra note 8, at 5 & n.2.
85. See Herzel & Shepro, supra note 7, at 122.
86. This disparate treatment among shareholders is what has prompted several courts con-
sidering the flip-in provisions to find unlawful discrimination. See supra note 49.
87. Under the Federated plan, common stockholders could purchase shares at a 50% dis-
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ing events.89 The purpose of flip-in provisions is to ensure that target
shareholders are not pressured into selling their shares for fear of the
acquiror utilizing coercive tactics or proceeding with a squeeze-out
merger.90 Flip-in provisions also encourage acquirors to negotiate91 with
the target company's board of directors during a takeover contest to
avoid dilution in the value of the target's shares.9 2 Recently, corpora-
tions have begun to strengthen their flip-in pills by increasing the exer-
cise price of the rights,9" lowering the acquisition threshold,94 and
eliminating the "window period" before the rights become
nonredeemable.9 5
Back-end or note purchase plans98 involve the issuance of rights
9 7
to common shareholders that allow the shareholders other than the ac-
count. CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,118.
88. Herzel & Shepro, supra note 7, at 122 n.21. Herzel and Shepro have identified self-deal-
ing transactions by an acquiror that create flip-in rights as including:
(1) mergers of the [acquiror] or an affiliate into the target, where the other stockholders are
not squeezed out; (2) transfers of assets to the target for target stock; (3) sales, purchases, or
pledges to, from, or with the target of any assets; (4) receipt of employment compensation
from the target; (5) receipt of loans from the target; and (6) reclassifications, such as reverse
stock splits, that increase the [acquiror]'s percentage holdings.
Id.; see also Dawson, Pence & Stone, supra note 7, at 428.
89. The same triggering events that applied to Federated's flip-over provision applied to its
flip-in provision. See supra notes 76-78 and accompanying text.
90. 1 TAKEOVER DEFENSES, supra note 2, at 122.
91. See supra note 28 and accompanying text.
92. In a letter to the firm's corporate clients, dated July 14, 1987, Martin Lipton suggested a
revised flip-in provision that would be triggered at a 20% acquisition threshold. Lipton Letter,
supra note 12, at 2. The 20% threshold is designed to prevent a raider from sweeping the street or
otherwise acquiring control through market purchases or a partial tender offer. Id. The new plan
also provides for a shareholder vote if a nonabusive takeover is proposed. Id. at 3. If a bidder who
does not hold more than 1% of the shares of the target proposes to acquire all of the shares of the
target for cash at a fair price and has financing commitments for its bid, the company must, at the
bidder's request, hold a special shareholders' meeting to vote on a resolution requesting the tar-
get's board to accept the bidder's proposal. Id. The shareholders' meeting, one half of the cost of
which must be paid by the acquiror, would be held within 90-120 days after the bidder's request.
Id. at 5. If a majority of the owners of the outstanding shares of the company approves the bid-
der's resolutions the pill would be redeemed and the bidder and the target could either enter into a
merger agreement or the bidder could make a bid for 100% of the company. Id.
93. Increasing the exercise price of the rights has the effect of making the rights plan more
dilutive to prospective acquirors and reduces the risk that an acquiror would be willing to "swallow
the pill."
94. Lowering the acquisition threshold to 10% is designed to deter open market purchases
and street sweeps. The effect is to require prospective acquirors to compete by means of a tender
offer, which requires equal treatment of shareholders and full disclosure.
95. Richards, Brussard & Williams, supra note 13, at 29, col. 1. Eliminating the 10-day win-
dow period prevents an acquiror from quickly gaining a large position in the stock of the target
and forcing the board of directors to redeem the rights.
96. See supra notes 50-51. While flip-over plans focus on the second step in an acquisition
and typically provide protection only in the event of a second-step transaction, note purchase
plans provide protection even if there is no second step.
97. The rights typically are issued as a pro-rata dividend.
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quiror to "put""8 their stock to the issuer for a specified package of
securities99 following the occurrence of certain triggering events.100 The
effect of the back-end plan, if the takeover is successful, is to require
the acquiring company to buy out the remaining shareholders at a price
established by the target's management. 101 Because back-end pills,
when triggered, involve an exchange offer that is not open to all share-
holders, they are similar in financial effect to discriminatory self-tender
offers10 2 and, thus, may be illegal 0 3 under the Securities Exchange Act
of 1934.104 Although note purchase right plans may provide valuable
protection to shareholders when adopted in response to a partial or
two-tiered tender offer, 105 they are not favored currently by corpora-
tions because of their suspect legal status. 106
In contrast to the economic rights plans, voting rights plans involve
the issuance of securities'07 with special voting powers to all of the tar-
get company's common shareholders. 08 In one version of the voting
rights plan, the target issues preferred stock'19 that grants supervoting
98. Note purchase plans are sometimes called "put" pills. Put pills usually are issued in the
context of a specific, unsolicited bid. See 1 A. FLEISCHER, supra note 7, at 70; 1 TAKEOVER DE-
FENSES, supra note 2, at 101.
99. See 1 TAKEOVER DEFENSES, supra note 2, at 102. A package of "securities may contain
provisions designed to make a bidder's financing more difficult or unobtainable, such as restric-
tions upon incurrence of debts sales of assets and maintenance of certain financial ratios." Id. The
value of the securities package in the note purchase plan may be intended to reflect the high end
of the long-term, realizable value of the issuer over the duration of the plan, or to reflect the
present minimum "fair value" of the issuer. Dawson, Pence & Stone, supra note 7, at 429.
100. Typically, the acquisition of 30% to 50% of the issuer's capital stock will be treated as a
triggering event. POISON PILL ECONOMICS, supra note 8, at 6.
101. The effect of these plans is to deter, or effectively to reject, partial tender offers, front-
end loaded, two-tiered acquisitions, and certain open market purchases and to establish a mini-
mum price for nonnegotiated takeovers. Dawson, Pence & Stone, supra note 7, at 429.
102. See 1 A. FLEISCHER, supra note 7, at 70-71; Herzel & Shepro, supra note 7, at 118-21.
103. See 1 A. FLEISCHER, supra note 7, at 71. Reacting "to Unocal's exclusionary self-tender
offer in response to Mesa Petroleum's takeover threat, the SEC proposed a rule requiring self-
tenders to be open to all of an issuer's stockholders." Id. The "all-holders" rule is now effective.
See 17 C.F.R. § 240.14(d)(10)(a)(1) (1986).
104. See 1 A. FLEISCHER, supra note 7, at 71. Fleischer has noted:
The SEC staff has indicated in "no action" letters that, under certain circumstances, it may
view the operation of a put right as a transaction subject to the self tender rules; in the case
of the Allied Stores put pill, the SEC advised the district court that the terms of that put pill
were subject to the all-holders rule.
Id.
105. See supra note 101 and accompanying text.
106. The courts also have not reacted favorably to note purchase plans. See cases cited supra
note 51.
107. The securities may be supervoting common stock or multiple or scaled voting preferred
stock. See Selected Tactics in Control Contents, supra note 46, at 90-91.
108. See POISON PIL ECONOMICS, supra note 8, at 7; Dawson, Pence & Stone, supra note 7,
at 430.
109. See Dawson, Pence & Stone, supra note 7, at 430.
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privileges" to all shareholders, except for the acquiror,"' upon the oc-
currence of a triggering event.112 Under another version, the target in
response to a tender offer'" issues preferred stock"4 that confers voting
rights which increase with the holding period of the stock," 5 preventing
those shareholders who sell their stock to the bidder from transferring
full voting power. 1 6 Both of these versions result in a severe dilution of
the voting power of the acquiror seeking control. 1 7 Several courts inter-
preting state law,"l8 however, have invalidated these voting plans on the
basis of discrimination.' 9
C. The Validity Debate
Proponents of poison pill plans12 argue that shareholder rights
plans give a target corporation's board of directors the power to protect
shareholders from the potentially coercive tactics of a hostile bidder.'
21
In addition to discouraging front-end loaded and partial tender of-
110. See ASARCO Inc. v. M.R.H. Holmes A. Court, 611 F. Supp. 468, 471 (D.N.J. 1985).
Each share of the new preferred stock was to be entitled to 50 votes on all matters submitted to
shareholders. However, once any person owned more than 20% of ASARCO's common stock or the
new preferred stock, any preferred shares owned by the 20% holder were stripped of all voting
rights. Id.
111. This is the discriminatory feature of the voting provisions.
112. In ASARCO the acquisition threshold was 20%. ASARCO, 611 F. Supp. at 471.
113. See Unilever Acquisition Corp. v. Richardson-Vicks, Inc., 618 F. Supp. 407, 408
(S.D.N.Y. 1985).
114. Id. The new series of preferred stock was proposed to be issued in a ratio of one share
for every five shares of common stock. Id.
115. Id. The preferred shares were to have been convertible at any time into five shares of
common stock and were to have five votes per share. However, if the preferred shares were owned
by the same person since the time of their original issuance, or for a continuous period of more
than 36 months, that holder would have had 25 votes per share. Id.
116. Id. Those persons who decided to sell their shares pursuant to the Unilever offer only
could sell diminished voting rights, and those who decided to retain their shares retained greater
voting rights. Id.
117. Dawson, Pence & Stone, supra note 7, at 430-31.
118. See cases cited supra note 51.
119. PoisoN PILL ECONOMICS, supra note 8, at 7.
120. Poison pill plans are supported widely by a large number of the Fortune 500 companies.
See supra note 12; see also Brownstein, Rights Plans: Still the Most Effective Defense, 1 INSIGHTS,
July 1987, at 9, 9 & n.3. The Brownstein article cites data compiled by Wachtell, Lipton, Rosen &
Katz, through April 2, 1987, that indicates adoption of poison pills by 38% of the Fortune 100
companies, 40% of the Fortune 200 companies, and over 32% of the Fortune 500 companies. Id.
The most notable and prolific of the plans' supporters is Martin Lipton, a partner with the New
York law firm of Wachtell, Lipton, Rosen & Katz. Lipton is credited with inventing the share-
holder rights plan.
121. See Moran, 500 A.2d at 1349 (Lipton discussing the frequency of "bust-up" takeovers as
a justification for the adoption of a pill); see also Dynamics Corp. of America v. CTS Corp., 635 F.
Supp. 1174, 1178 (N.D. 111. 1986) (discussing the "threat" or "evil" posed by squeeze out mergers);
supra notes 35-44 and accompanying text.
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fers, ' 2 2 the pills deter large shareholders from engaging in self-dealing
transactions.12 3 Supporters of the shareholder rights plans also contend
that the plans force an acquiror to negotiate the terms of a business
combination with the target's board.24 Moreover, some commentators
argue that the pills furnish target directors and management with the
bargaining power necessary to force raiders to pay substantially higher
premiums for the target's stock.'2 5 Empirical studies confirm the propo-
nents' belief that poison pills enacted by directors help maximize share-
holder wealth in hostile bidding contests. 26 Without the pills, the
122. See 1 TAKEOVER DEFENSES, supra note 2, at 99-100; supra notes 36-37 and accompany-
ing text.
123. See supra note 42 and accompanying text.
124. The commentators note the effect of a poison pill on the negotiating power of a target's
board of directors. They observe that poison pills create substantial uncertainty in the pricing of a
tender offer and a nonnegotiated business combination; provide bargaining power to the issuer's
directors by making a nonnegotiated acquisition extremely difficult and expensive; and delay a
nonnegotiated potential bid, thus permitting the target's board to negotiate a better deal, to seek
out a white knight, or to put together a higher bid sponsored by management. See supra notes 28,
43-44 and accompanying text; see also Dawson, Pence & Stone, supra note 7, at 431-32.
125. Lee, "Poison Pills" Benefit Shareholders by Forcing Raiders to Pay More for Targets,
Study Says, Wall St. J., Mar. 31, 1988, at 55, col. 2, 3 (quoting Martin Lipton in stating that "[t]he
study confirms that the pill 'is the most effective way to equalize the negotiating strength of man-
agement with the overwhelming advantage that the corporate raider has' "); see also Baysinger &
Butler, Antitakeover Amendments, Managerial Entrenchment, and the Contractual Theory of
the Corporation, 71 VA. L. REV. 1257, 1300 (1985) (stating that antitakeover measures may allow
incumbent management not only to maximize the price of a company's stock but also to reduce
agency costs associated with the market for corporate control); Lipton, Corporate Governance,
supra note 5, at 31 (arguing that a shareholder rights plan forces a raider to negotiate with the
target's board and ensures that the raider will not abuse the tender offer process); Oesterle, supra
note 28, at 155 (concluding that plans that are intended to delay tender offers in order to coax a
better price from a bidder or to stimulate an auction should receive preferential treatment by
courts); Oesterle, Target Managers as Negotiating Agents for Target Shareholders in Tender Of-
fers: A Reply to the Passivity Thesis, 71 CORNELL L. REV. 53, 53 & n.4 (1985) [hereinafter Oesterle,
Target Managers] (contending that shareholder wealth may be optimized by target management
acting responsibly as bargaining agents). See generally R. POSNER & K. SCOTT, ECONOMICS OF COR-
PORATION LAW AND SECURITmS REGULATION 195-231 (1980); Herzel, Schmidt & Davis, Why Corpo-
rate Directors have a Right to Resist Tender Offers, 3 CoRP. L. REV. 107, 109-10 (1980) (arguing
that a board through negotiation can force the offeror to raise the premium, persuade the bidder to
accept more favorable terms, or seek other bidders). Indeed, directors may have a fiduciary duty to
maximize the control premium for shareholders. See, e.g., Smith v. Van Gorkom, 488 A.2d 858, 893
(Del. 1985) (finding that managers violated their fiduciary duty by not soliciting alternative offers
and not providing information to their stockholders).
126. Lee, supra note 125, at 55, col. 2. The study was conducted by New York proxy solicitor
Georgeson & Co., which has helped companies defend their poison pills against shareholder chal-
lenges. Although the objectivity of Georgeson is questionable, the study showed that 27 companies
with pills received final offers at an average of 78.5% above where their stock was trading six
months before the takeover contests began; whereas, the 21 companies without pills averaged only
a 56.7% gain. Id.
Adjusting for movement in the Standard & Poor's 500-stock Index, companies with pills out-
performed the index by an average of 52.7%, while those without pills beat the index by an aver-
age of 31.3%. Id. Critics argue that the study fails to cite conclusions as to the causes of the higher
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premiums would not be attainable because shareholders typically are
dispersed widely and unable to negotiate collectively. 2 7 Finally, sup-
porters contend that shareholder rights plans are more favorable than
other types of defensive tactics, such as a "scorched earth defense," be-
cause they do not result in a major structural change in the business or
in the financial or earnings capacity of the target. 128
Critics argue that defensive tactics in general, and poison pill plans
in particular: (1) transfer power from stockholders to directors; (2) en-
trench management; (3) preclude all takeovers; and (4) decrease share-
holder wealth.129 Institutional investors and corporate raiders are the
most vehement opponents of shareholder rights plans.130 These groups
complain that poison pill plans almost always are adopted by a board of
directors without shareholder approval.3' and, thus, deprive sharehold-
ers the opportunity to decide if a takeover is in the best interests of a
corporation. 3 2 Many commentators argue that in effect this transfer of
premiums and the effects of the pills on takeovers that were never completed or initiated. See
Lipton, Corporate Governance, supra note 5, at 31 n.132. Lipton cites a Kidder, Peabody & Co.
study which found that stock prices of 75% of the companies surveyed increased following the
announcement of a poison pill plan and that the companies, as a whole, outperformed the Stan-
dard & Poor's 400 Index. Id. But see POISON PILL EFFECTS, supra note 8, at 43 (concluding that
"poison pills are harmful to target shareholders"); POISON PIL ECONOMICS, supra note 8, at 13-14
(stating that "the market considers the typical poison pill to be significantly harmful to share-
holder welfare").
127. See Lowenstein, supra note 36, at 267.
128. 1 TAKEOVER DEFENSES, supra note 2, at 100.
129. See POISON PILL ECONOMICS, supra note 8, at 13-15; 1 TAKEOVER DEFENSES, supra note
2, at 100-01; see also Brownstein, supra note 120, at 9; Jarrell, Brickley & Netter, supra note 1, at
58-59, 63-64; Jensen, supra note 1, at 41-44; Note, Developments in the Use of the Poison Pill,
supra note 7, at 1086-87. In 1981 Professors Frank H. Easterbrook and Daniel R. Fischel advanced
the passivity thesis for takeovers which proposes that the management of a target corporation
subject to a tender offer should be prohibited from resisting the offer in any manner. See Easter-
brook & Fischel, The Proper Role of a Target's Management in Responding to a Tender Offer, 94
HARv. L. REV. 1161 (1981) [hereinafter Easterbrook & Fischel, Target Management's Role]; see
also Easterbrook & Fischel, Corporate Control Transactions, 91 YALE L.J. 698 (1982) [hereinafter
Easterbrook & Fischel, Corporate Control]; Easterbrook & Fischel, Auctions and Sunk Costs in
Tender Offers, 35 STAN. L. REV. 1 (1982) [hereinafter Easterbrook & Fischel, Auctions and Sunk
Costs]; Easterbrook & Fischel, Antitrust Suits by Targets of Tender Offers, 80 MICH. L. REV. 1155
(1982).
130. Institutional Investors Oppose Poison Pill Plans, IRRC Survey Shows, 19 Sec. Reg. &
L. Rep. (BNA) No. 46, at 1751-52 (Nov. 20, 1987). A study released by the Investor Responsibility
Research Center indicated that 81% of the institutional investors responding to the group's annual
survey supported shareholder resolutions asking companies to rescind their poison pills or put
them to a shareholder vote. Id. at 1751.
131. Id.
132. Easterbrook & Fischel, Auctions and Sunk Costs, supra note 129, at 1. Professors Eas-
terbrook and Fischel question the competence and the motives of corporate officers who defend
against hostile tender offers, asserting that target managers who engage in defensive tactics rarely
do so in the best interests of the shareholders. Id. But see Brownstein, supra note 120, at 9 (argu-
ing that a policy of passivity is not consistent with the legal standards of directorial responsibility
and ignores the reality that shareholders are a widely dispersed body).
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power from the stockholders to the directors results in the entrench-
ment of the current management and board of directors."' Critics also
contend that the severe consequences of the shareholder rights plans13 4
deter all unsolicited tender offers. 3 '
Opponents of the poison pill plans further argue that the plans re-
duce both shareholder and social welfare.'3 6 Professors Frank H. Eas-
terbrook and Daniel R. Fischel contend that even if target boards
defend against takeovers exclusively in the best interests of their share-
holders, there is a net reduction in shareholder and social wealth be-
cause of high agency costs.' 3 7 This view receives empirical support from
133. See 1 TAKEOVER DEFENSES, supra note 2, at 100; Easterbrook & Fischel, Auctions and
Sunk Costs, supra note 129, at 1. In most cases, resistance reflects either mismanagement (to the
extent it pointlessly denies shareholders the opportunity to obtain a premium) or manager's self-
protection (to the extent its point is to preserve managers' jobs or "sell" their acquiescence in
exchange for bonuses or promises of future employment). See Note, Developments in the Use of
the Poison Pill, supra note 7, at 1086. But see Moran, 500 A.2d at 1354 (stating that "[t]here is
little change in the governance structure as a result of the adoption of the Rights Plan"); Oesterle,
Target Managers, supra note 125, at 56-73 (contending that target managers can act virtuously as
bargaining agents for target shareholders).
134. See supra note 28 and accompanying text.
135. 1 TAKEOVER DEFENSES, supra note 2, at 104-05. The SEC raised the following argument
in its amicus curiae brief in the Moran cases: "The Chancery Court's decision seriously understates
the impact of this plan. In fact, as we discuss below, the Rights Plan will deter not only two-tier
offers, but virtually all hostile tender offers." Moran, 500 A.2d at 1354. But see Brownstein, supra
note 120, at 10. A study completed in April 1987 by Wachtell, Lipton, Rosen & Katz indicated
that, as of that time, 42 of the companies which had adopted poison pills (amounting to over 10%
of all the companies that adopted the plans) subsequently were acquired, with 17 of the 42 being
acquired by the initial hostile bidder. Id.
136. Commentators argue that society and investors benefit from takeovers that move corpo-
rate resources from less efficient managers to those who can use the resources more efficiently.
Efficiency gains are realized from business consolidations that result in greater integration of pro-
duction and more effective use of information, or "synergy." Managers of tender offer targets,
therefore, should not resist tender offers because takeovers allow shareholders to recognize these
gains by replacing inferior management. See Easterbrook & Fischel, Target Management's Role,
supra note 129, at 1164 (arguing for managerial passivity in the face of a takeover bid); Easter-
brook & Fischel, Takeover Bids, Defensive Tactics and Shareholders' Welfare, 36 Bus. LAW. 1733
(1981); Jarrell, Brickley & Netter, supra note 1, at 58-59, 63-64; Jensen, supra note 1, at 41-44. But
see Baysinger & Butler, supra note 125, at 1302; Lipton, Takeover Bids in the Target's Boar-
droom, 35 Bus. LAW. 101, 104-05 (1979) [hereinafter Lipton, Takeover Bids] (concluding that take-
over bids lower social welfare by constraining long-range planning); Lipton, Takeover Bids in the
Target's Boardroom-An Update after One Year, 36 Bus. LAW. 1017 (1981) [hereinafter Lipton,
Takeover Bids II] (citing judicial decisions affirming directors' actions that were reasonable in the
face of takeover bids); Oesterle, Target Managers, supra note 125, at 94-95 (arguing that share-
holder wealth can be optimized through judicial supervision of defensive tactics); supra note 126
and accompanying text.
137. Easterbrook & Fischel, Auctions and Sunk Costs, supra note 129, at 2. Professors Eas-
terbrook and Fischel believe that premium bids encouraged by defensive devises reduce private
and social gains. They state that "[t]he fact that the bid occurs at a premium over the market
price indicates that revamping the target's structure of management would generate private and,
in all likelihood, social gains. Resistance to the bid, if successful, frustrates the achievements of
these gains." Id. at 1. Professors Easterbrook and Fischel also believe that auctions reduce both
190
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a Securities and Exchange Commission study in which the Office of the
Chief Economist concluded that poison pills generally are harmful to
target shareholders' net."'8 Some opponents question the propriety of
evaluating poison pills and other such defensive tactics under the busi-
ness judgment rule.139
D. Current Regulation
Current federal legislation does not provide an answer to the de-
bate. 40 Federal regulation of coercive tender offers is limited essentially
to the enforcement of disclosure requirements.' 41 Recently, the United
States Supreme Court in CTS Corp. v. General Dynamics Corp. of
America 42 upheld the validity of Indiana's "Control Share Acquisition"
Statute143 and acknowledged the supremacy of the states in the area of
corporate governance.1 44 The law of the state of incorporation, there-
fore, governs judicial appraisal of directors who enact defensive mea-
sures when confronted with a tender offer.
shareholder and social welfare:
Drawing on a theoretical argument that investors would be willing to allow acquisitions for
bargain prices if that were necessary to promote outside monitoring, and on empirical work
establishing that the number of tender offers falls to the extent that state laws facilitate auc-
tioning, we conclude that auctions do not benefit investors as a group even though they may
raise the price realized in particular cases. By raising the price, auctions reduce the number of
acquisitions and thus the amount of monitoring. The decrease in monitoring results in higher
agency costs of management and thus in lower returns on investment. On this basis we con-
clude that all defensive tactics, whether or not for the purpose of triggering an auction, reduce
shareholders' wealth.
Id. at 2 (footnotes omitted). But see Bebchuk, The Case for Facilitating Competing Tender Of-
fers: A Reply and Extension, 35 STAN. L. REV. 23 (1982) (concluding that auctions increase both
shareholder and social wealth); Bebchuk, The Case for Facilitating Competing Tender Offers, 95
HARV. L. REV. 1028 (1982); Gilson, Seeking Competitive Bids Versus Pure Passivity in Tender
Offer Defense, 35 STAN. L. REV. 51 (1982); Gilson, A Structural Approach to Corporations: The
Case Against Defensive Tactics in Tender Offers, 33 STAN. L. REV. 819, 868-75 (1981) [hereinafter
Gilson, The Case Against Defensive Tactics].
138. POISON PILL EFFECTS, supra note 8, at 43; see also POISON PILL ECONOMICS, supra note
8, at 13-15; Jarrell & Bradley, The Economic Effects of Federal and State Regulations of Cash
Tender Offers, 23 J. L. & EcoN. 371, 398-403. But see Brownstein, supra note 120, at 10-11. Brown-
stein points out that the SEC's conclusion was reached only after several refinements eliminated
nearly 85% of the companies in the survey sample. The SEC's analysis of the entire 245 companies
in the sample found no statistically significant reduction of stock prices. Id. at 10.
139. See Easterbrook & Fischel articles cited supra note 129; see also Gilson, The Case
Against Defensive Tactics, supra note 137, at 822-23; Note, The Propriety of Judicial Deference
to Corporate Boards of Directors, 96 HARv. L. REV. 1894, 1910 (1983).
140. For a summary of recently proposed legislation, see supra note 4.
141. See, e.g., Sante Fe Indus. Inc. v. Green, 430 U.S. 462 (1977) (holding that without mate-
rial omissions or misstatements, merger transactions involving manipulation are beyond the pur-
view of general federal law).
142. 107 S. Ct. 1637 (1987).
143. IND. CODE ANN. §§ 23-1-42-1 to 23-1-42-11 (Burns Supp. 1988).
144. See Langevoort, supra note 33, at 1.
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Courts, interpreting state law, have devised their own standards for
reviewing defensive measures like poison pill plans. 145 For example, in
Moran the Delaware Supreme Court upheld the validity of a flip-over
plan against a challenge to the plan's legality under Delaware law.""6
However, more recent poison pill cases, which prohibit discrimination
among shareholders or impose strict standards of reasonableness for
triggering and payout provisions, have invalidated flip-in provisions and
vote purchase provisions in certain situations. 147 Today, poison pill liti-
gation involves two major issues: (i) whether the poison pill plan unlaw-
fully discriminates against the acquiror; and (ii) whether the adoption
of the plan will be protected by the business judgment rule in view of
new procedural and substantive standards established by recent
decisions. 48
III. THE VALIDITY OF POISON PILLS UNDER STATE CORPORATION
LAw-DISCRIMINATION
A typical shareholder rights plan provides that the common share-
holders may exercise and transfer certain rights upon the occurrence of
a triggering event. 49 Because acquiring shareholders commonly are ex-
cluded from the group entitled to fully exercise these rights, discrimina-
tory treatment among shareholders results which courts may find
unlawful' 50 or unauthorized.' 51 Interestingly, courts that have consid-
145. State courts traditionally have refused to second guess directors' actions in the tender
offer context and, instead, typically apply the business judgment rule to those board decisions.
See, e.g., Panter v. Marshall Field & Co., 646 F.2d 271, 293-95 (7th Cir.), cert. denied, 454 U.S.
1092 (1981) (business judgment rule protects board's decision to resist a takeover); see also Gear-
hart Indus. Inc. v. Smith Int'l, Inc., 741 F.2d 707, 723-24 (5th Cir. 1984) (holding that under Texas
law, no liability is imposed upon a disinterested corporate director unless the act was ultra vires or
fraudulent); Auerbach v. Bennett, 47 N.Y.2d 619, 629, 393 N.E.2d 994, 1000, 419 N.Y.S.2d 920, 926
(1979) (stating that the business judgment rule bars judicial inquiry into the actions of corporate
directors taken in good faith and in furtherance of legitimate business purposes). For a definition
of the business judgment rule, see infra note 151.
146. Moran, 500 A.2d at 1357.
147. See cases cited supra notes 49, 51.
148. See Aronson v. Lewis, 473 A.2d 805, 812 (Del. 1984). The traditional business judgment
rule involved:
a presumption that in making a business decision the directors of a corporation acted on an
informed basis, in good faith and in the honest belief that the action taken was in the best
interests of the company. Absent an abuse of discretion, that judgment will be respected by
the courts.
Id. (citations omitted).
149. See supra notes 18-21 and accompanying text.
150. See, e.g., DEL. CODE ANN. tit. 8, § 212 (1983); N.H. REV. STAT. ANN. § 19A:5-10 (1969);
Wis. STAT. ANN. § 180.25(i) (West Supp. 1987). But see Oesterle, supra note 28, at 131 n.58 (argu-
ing that the real issue is whether poison pill plans benefit target shareholders, and court findings of
illegal discrimination among shareholders of the same class merely cloud the basic issue).
151. This assumes the shareholders did not approve the poison pill plan. See, e.g., Unilever
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ered plans that discriminate among shareholders of the same class have
reached different conclusions.
Recent cases interpreting New York,152 New Jersey,153 and Colo-
rado154 law have invalidated poison pills that discriminate against an
acquiror. These decisions rest on the principle that at least when share-
holder approval has not been obtained, the state law in question does
not permit discrimination among similarly situated shareholders. 55
Under New Jersey corporate law a board of directors may amend
the articles of a corporation to issue new stock and to specify the
stock's relative rights, preferences, and limitations when authorized to
do so in the certificate of incorporation.' 56 In ASARCO Inc. v. M.R.H.
Holmes A. Court 57 the New Jersey court determined that New Jersey
law did not grant the board of directors the authority to reapportion
the voting powers of shareholders within the same class. The court rea-
soned that in light of the general rule entitling each shareholder to one
vote, the board only possessed the authority to alter rights and prefer-
ences between different classes of stock. 8 In ASARCO the board
sought to issue preferred stock as a dividend to common shareholders
to increase their voting power. However, the preferred stock was exer-
cisable only in the event that any person or group acquired twenty per-
cent or more of ASARCO's stock, 5 9 and a shareholder of twenty
percent or more was not entitled to exercise the increased voting
power. 10 Emphasizing the basic corporate law concept of equality in
voting power among shareholders of the same class, the ASARCO court
held that the preferred stock in question was discriminatory and, thus,
Acquisition Corp. v. Richardson-Vicks, Inc., 618 F. Supp. 407, 410 (D.C.N.Y. 1985) (change in
corporate structure of great magnitude requires stockholder approval under DEL CODE ANN. tit. 8,
§ 202(b) (1983)). Section 202(b) provides that "no restriction so imposed [on the transfer of shares]
shall be binding with respect to securities issued prior to the adoption of this restriction unless the
holders of the securities are parties to an agreement or voted in favor of the restriction." DEL.
CODE ANN. tit. 8, § 202(b) (1983).
152. See Bank of New York Co., Inc. v. Irving Bank Corp., Transcript of Oral Opinion (N.Y.
Sup. Ct. July 6, 1988), aff'd, No. 34386 (N.Y. App. Div. Oct. 4, 1988) (source on file with Author).
153. See Amalgamated Sugar Co. v. NL Indus., 644 F. Supp. 1229 (S.D.N.Y. 1986), afi'd, 825
F.2d 634 (2d Cir. 1987); Minstar Acquiring Corp. v. AMF, Inc., 621 F. Supp. 1252 (S.D.N.Y. 1985);
ASARCO Inc. v. M.R.H. Holmes A. Court, 611 F. Supp. 468 (D.N.J. 1985).
154. See Spinner Corp. v. Princeville Dev. Corp., No. 86-0701 (D. Haw. Oct. 31, 1986) (inter-
preting Colorado law).
155. Amalgamated Sugar, 644 F. Supp. at 1234.
156. N.J. STAT. ANN. § 14A:7-1(1) (West 1969).
157. 611 F. Supp. 468 (D.N.J. 1985).
158. Id. at 477.
159. Id. at 471.
160. Id. The preferred stock voting provisions effectively blocked any acquisition not ap-
proved by management. Id.
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illegal under New Jersey corporate law.16'
Likewise, in Minstar Acquiring Corp. v. AMF, Inc.,162 the District
Court for the Southern District of New York found that a poison pill's
restriction on the alienability of shares was unlawful under New Jersey
corporate law.16 3 AMF's board of directors wished to ensure that
nontendering shareholders would receive fair value for their stock in
the event of a hostile takeover. Therefore, the board adopted a plan to
distribute a dividend 6 4 to all common shareholders that entitled the
shareholders, upon the occurrence of a triggering event, to exchange
their stock for subordinated debentures carrying a favorable rate of in-
terest.' 5 These rights, however, were not transferrable.16 The common
shareholders could neither trade these rights with their common stock,
nor transfer the rights separately after the occurrence of the triggering
event. Consequently, only those shareholders who held their shares as
of the date of the distribution of the rights were entitled to convert
their stock.167 Finding that this nontransferability constituted an illegal
restraint on the alienability of the stock, 6 8 the court enjoined the AMF
board from implementing the discriminatory poison pill plan. 69
In Amalgamated Sugar Co. v. NL Industries170 the District Court
for the Southern District of New York enjoined the use of a shareholder
rights plan adopted by the directors of NL Industries (NLI).' Under
the plan, each common shareholder received a dividend of one right per
share. 172 These rights were triggered when a shareholder or group accu-
mulated twenty percent or more of NLI common stock, or a tender of-
fer was made for thirty percent or more of NLI stock.173 The triggering
161. Id. at A77. According to the ASARCO court, "[e]quality of voting power among stock-
holders of the same class, or at least among the same series of a class that has more than one
series, is a basic concept of corporate law." Id.; accord Baker v. Providence & Woosler Co., 364
A.2d 838, 847 (Del. Ch. 1976), rev'd, 378 A.2d 121 (Del. 1977). The ASARCO court rejected the
distinction drawn in Providence between discrimination among shareholders, which was not found
to violate the law, and discrimination among the shares of stock, which was deemed a statutory
violation. ASARCO, 611 F. Supp. at 478.
162. 621 F. Supp. 1252 (S.D.N.Y. 1985).
163. Id. at 1258.
164. Id. at 1256. The dividend was in the form of a right.
165. Id. The interest rate was to have been 14.5%. Id.
166. Id. at 1257.
167. Id. at 1258.
168. Id. at 1259-61.
169. Id. at 1259. The court stated that "such major changes in structure and voting rights
may only be approved by the shareholders." Id. The Minstar court did not cite authority for this
proposition.
170. 644 F. Supp. 1229 (S.D.N.Y. 1986), afl'd, 825 F.2d 634 (2d Cir. 1987).
171. Id. at 1240.
172. Id. at 1232.
173. Id. at 1232. Upon the occurrence of the triggering event, the rights certificates were to
be distributed to all shareholders.
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event activated either the flip-in or the flip-over provision, depending
upon the circumstances of the acquisition.174 The New York court scru-
tinized the plan's flip-in provision, 17 5 which prohibited the acquiror
from exercising the rights made available to the other shareholders.171
Declining to follow Delaware corporate law17 7 the Amalgamated Sugar
court interpreting New Jersey law concluded that because the flip-in
provision subjected the acquiror's interests, voting rights, and equity to
discriminatory dilution, 8 the plan unlawfully discriminated against
shareholders of the same class. 179
The Delaware Supreme Court has not expressly addressed the dis-
crimination issue because the court concluded that by definition the
flip-over pill upheld in Moran did not discriminate against the ac-
quiror.180 Under certain other circumstances, however, discrimination
against an acquiror has been upheld under Delaware law. In Revlon,
Inc. v. MacAndrews & Forbes Holdings, Inc."' the Delaware Supreme
Court stated in dicta that Revlon's note purchase rights plan, which
provided note purchase rights to all shareholders except the acquiror,
was not unlawful.182 Although the Revlon court did not address the dis-
crimination issue explicitly, it concluded that the board clearly had the
power to adopt the note purchase plan, as long as there was a reasona-
ble purpose for this corporate measure. 83
In Unocal Corp. v. Mesa Petroleum Co."'8 the Delaware Supreme
Court approved a defensive issuer self-tender offer that excluded Mesa
Petroleum, which was then making a bid for Unocal.'85 The court stated
that there was "no support in Delaware law for the proposition that,
when responding to a perceived harm, a corporation must guarantee a
benefit to a stockholder who is deliberately provoking the danger being
addressed. ' ' 18 6 Because it did not address the legality of a discrimina-
174. Id. at 1232.
175. Id. at 1234-39.
176. Id. at 1233.
177. The Amalgamated Sugar court cited Providence & Worcester Co. v. Baker, 378 A.2d
121 (Del. 1977), rev'g, 364 A.2d 838 (Del. Ch. 1976).
178. Amalgamated Sugar, 644 F. Supp. at 1234-35.
179. Id. at 1235.
180. Moran, 500 A.2d at 1354.
181. 506 A.2d 173 (Del. 1986).
182. Id. at 180.
183. Id. In reaching its decision, the Revlon court cited Moran and §§ 141 and 122(13) of the
Delaware General Corporation Law. The statutory provisions cited by the court essentially state
that corporations can incur debt obligations and do not address the subject of discrimination
among shareholders.
184. 493 A.2d 946 (Del. 1985).
185. Id. at 951.
186. Id. at 958.
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tory poison pill plan, Unocal is not controlling law. However, Unocal
and Revlon taken together suggest that the Delaware Supreme Court
probably would not invalidate a poison pill solely because it is discrimi-
natory. Decisions interpreting the corporate law of Indiana, Minnesota,
and Michigan also reach this result, concluding that flip-in poison pill
plans discriminate among shareholders, rather than among shares of a
particular class of stock, and, therefore, do not violate the antidis-
crimination provisions of the state statute involved.81
In Dynamics Corp. of America v. CTS Corp.'a8 an Illinois district
court applying Indiana law ultimately enjoined the use of a flip-in plan
on the basis of the board's failure to comply with the business judgment
rule.1 89 However, the court discussed the plan's flip-in provision in dic-
tum, looking to Delaware corporate law for guidance. The Dynamics
court cited with approval the position taken by the Delaware courts on
the discrimination issue, 90 and specifically stated that it was not con-
cluding that all flip-in provisions were illegal.' 9 Although not binding,
the Dynamics opinion indicates the possibility that flip-in provisions
may be upheld under Indiana or Delaware law.
On the other hand, in Unilever Acquisition Corp. v. Richardson-
Vicks, Inc.,92 a New York court applying Delaware law invalidated a
new class of preferred stock issued in the middle of a takeover fight
that provided for different voting rights 93 within the same class of
stock depending upon when the stock was acquired and how long it was
held. 9 4 The Unilever court distinguished Unocal on the ground that
187. See Harvard Indus. v. Tyson, [1986-1987 Transfer Binder] Fed. Sec. L. Rep. (CCH) 1
93,064, at 95,294 (E.D. Mich. Nov. 25, 1986) (bench opinion denying motion for preliminary in-
junction) (the court adopted "the position of the better-reasoned cases that such a rights plan does
not discriminate among shares, but rather, among shareholders, which is not forbidden" under
Michigan law); Gelco Corp. v. Coniston Partners, 652 F. Supp. 829 (D. Minn. 1986), aff'd in part,
vacated in part, 811 F.2d 414 (8th Cir. 1987) (holding that Minnesota law, which is patterned on
Delaware law, does not prohibit discriminatory poison pill plans); Dynamics Corp. of America v.
CTS Corp., 637 F. Supp. 406 (N.D. Ill.), afl'd, 794 F.2d 250 (7th Cir. 1986) (rejecting the argument
that the flip-in provision of the CTS poison pill plan was unlawful under Indiana law, which the
court treated as essentially the same as Delaware law, because the provision discriminated against
the acquiror).
188. 637 F. Supp. 406 (N.D. Ill.), afl'd, 794 F.2d 250 (7th Cir. 1986).
189. Id. at 418.
190. Id. at 408-09.
191. Id.
192. 618 F. Supp. 407 (S.D.N.Y. 1985).
193. Each share of preferred stock entitled the holder to cast 25 votes on all issues upon
which the holders of the common stock could vote. However, if the preferred stock was transferred
(e.g., to a hostile bidder), the new holder could exercise only 5 of these 25 votes for the first 36
months that the preferred stock was held. Id. at 408.
194. Id. at 410 (stating that "[u]nder Delaware law, a change in corporate structure of this
magnitude, reducing the transferability of a shareholder's ability to vote and the value of his or her
asset to this degree, requires stockholder approval which has not been obtained").
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Unocal involved what was permissible when a board was reacting to the
advances of a well known "greenmailer,' ' 9 5 and focused on the fact that
Richardson-Vicks' certificate of incorporation explicitly provided that
all shares of any one series of preferred stock would be identical with
each other.196 Read in conjunction with the cases mentioned above
which follow the New Jersey line of reasoning, Unilever could form the
basis for an argument that Delaware law should be extended to invali-
date discriminatory poison pill plans.
After Bank of New York Co. v. Irving Bank Corp.,1 9 flip-in provi-
sions that discriminate among shareholders of the same class appear to
be invalid under New York corporate law."9 8 The New York Supreme
Court in Bank of New York considered the legality of Irving Bank Cor-
poration's (IBC) flip-in rights amendment that entitled each right
holder, with the exception of a person or entity holding twenty percent
or more of the shares of IBC, to purchase 400 dollars of IBC common
shares for 200 dollars if any person or entity acquired twenty or more
percent of the shares of IBC.1" Although Justice Cahn noted that the
flip-in amendment would make an acquisition of twenty percent or
more of the IBC shares prohibitively expensive, 00 he implied that the
amendment might increase the incentive for negotiation between the
acquiror and IBC's board of directors.20 1 The court, however, avoided
evaluating the board's adoption of the flip-in provision under the busi-
195. Id.
196. Id.
197. Transcript of Oral Opinion (N.Y. Sup. Ct. July 6, 1988), a/I'd, No. 34386 (N.Y. App.
Div. Oct. 4, 1988) (source on file with Author); see also New York Court Enjoins Enforcement of
Discriminatory Flip-In Provision, 20 Sec. Reg. & L. Rep. (BNA) No. 32, at 1275 (Aug. 12, 1988)
[hereinafter New York Court].
198. The Bank of New York sought a preliminary injunction preventing Irving Bank from
executing the flip-in provision of its poison pill. The Bank of New York argued that the flip-in
amendment adopted by Irving Bank's board of directors on May 19, 1988, was ultra vires as a
matter of New York corporate law. Bank of New York, Transcript of Oral Opinion at 4.
199. Id. at 6. The court noted that the shareholder rights agreement "greatly dilutes the
twenty percent shareholder's equity and voting rights and thus makes acquisition of all or a major-
ity of the shares extremely expensive for the twenty percent acquirers." Id. at 7.
200. Id. at 6-7. The court explained that if triggered when a common share of IBC was trad-
ing at $72 per share, the flip-in provision would entitle "each IBC right holder, with the exception
of the twenty percent or more holder . . . to purchase from IBC approximately five and four-
sevenths shares of IBC for $200, while the twenty percent holder could buy none from IBC." Id. at
7. The court noted that even if the acquiring shareholder were able to purchase shares freely on
the open market, he could only "obtain less than three shares per $200 expenditure and thus
obtain less than four shares and votes per shares previously owned, plus $200;" whereas, the other
rights holders would "have more than six shares and votes for each common share previously
owned, plus $200." Id. at 7-8.
201. Id. at 6. Justice Calm stated: "[T]he agreement has the effect of making acquisition of
twenty percent or more of IBC shares prohibitively expensive and unprofitable unless the IBC
Board approves such acquisition, at which time the IBC Board can have IBC redeem the rights."
Id. at 6.
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ness judgment rule20 2 and, instead, found the discriminatory effects of
the pill impermissible under New York statutory corporate law.203
The Bank of New York sought to have the flip-in provision en-
joined on the grounds that it violated section 501 of New York's Busi-
ness Corporation Law,204 which directs that each share in the same class
must be equal. 20 5 Bank of New York argued that the flip-in portion of
the IBC pill discriminated among shares of the same class by allowing
only those shareholders who own less than twenty percent to purchase
IBC shares at a fifty-percent discount.206 IBC contended that no issue
of discrimination existed among shares because section 505,07 which
does not contain a prohibition against discrimination among shares of
the same class, governed the rights issued by their board.208 In addition,
IBC argued that section 622209 of New York Business Corporation Law
authorizes discriminatory treatment between shareholders by providing
a corporation with a method for disallowing shareholders to exercise
their preemptive rights to preserve their voting and dividend power.10
Following the reasoning in Amalgamated Sugar21 1 and FeBland v. Two
Trees Management Co., 212 the Supreme Court of New York concluded
that the express prohibition against discrimination in section 501(c)
may not be avoided by a provision in a corporation's certificate of incor-
poration under section 622.213 The court, therefore, granted Bank Of
New York's motion for a preliminary injunction, preventing IBC's
board of directors from enforcing the flip-in provision of its poison
202. Id. at 5. The court noted that it did not attempt to arrive at any decision as to which
offer-that of the Bank of New York or the contender, Banco Commerciale Italiana-was superior
because that decision, if it involves "business judgment," is for the board of directors. Id. at 5. The
court also found it unnecessary to evaluate whether the flip-in provision would be protected by the
business judgment rule. For an analysis of the factors that would be considered in determining
whether the actions of the IBC board would be protected, see infra notes 220-80 and accompany-
ing text. Perhaps, the New York court would have found the flip-in provision adopted by IBC a
reasonable response to the threat posed by Bank of New York's offer.
203. Bank of New York, Transcript of Oral Opinion at 10.
204. N.Y. Bus. CORP. LAW § 501(C) (McKinney 1986). Section 501(c) states that "subject to
the designations, relative rights, preferences and limitations applicable to separate series, each
share shall be equal to every other share in the same class." Id.
205. Bank of New York, Transcript of Oral Opinion at 8 (quoting the New York statute).
206. Id. at 8.
207. N.Y. Bus. CORP. LAW § 505 (McKinney 1986).
208. Bank of New York, Transcript of Oral Opinion at 9.
209. N.Y. Bus. CORP. LAW § 622 (McKinney 1986).
210. Bank of New York, Transcript of Oral Opinion at 9. Under § 622, a corporation may
include in its certificate of incorporation a provision that denies its shareholder preemptive rights.
N.Y. Bus. CORP. LAW § 622 (McKinney 1986); see also Bank of New York, Transcript of Oral
Opinion at 9.
211. 644 F. Supp. 1229.
212. 66 N.Y.2d 556, 489 N.E.2d 223, 498 N.Y.S.2d 336 (1985).
213. Bank of New York, Transcript of Oral Opinion at 13.
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Recent decisions suggest that poison pills that discriminate against
an acquiror are illegal under the corporate laws of New York, New
Jersey, and Colorado.215 Under Delaware, Indiana, Michigan, and Min-
nesota law,216 however, discrimination against an acquiror is a factor
that may influence a court's decision as to whether a target's board
breached its fiduciary duty in adopting a shareholder rights plan. Two
states, Ohio21 and Wisconsin,218 have amended their corporation laws
to permit boards of directors to issue rights that prevent a holder of a
specified percentage from exercising those rights.21 9 Whether other
states will follow Ohio and Wisconsin in specifically validating discrimi-
natory flip-in pills remains unanswered.
IV. THE VALIDITY OF POISON PILLS UNDER STATE FIDUCIARY
LAW-THE BUSINESS JUDGMENT RULE
A. The Modified Business Judgment Rule
State courts traditionally have refused to second guess directors'
reactions to tender offers and instead have applied a relatively deferen-
tial "business judgment rule" to those board decisions.220 The business
judgment rule creates a rebuttable presumption 221 that a board's ac-
tions are taken in good faith and "in the best interest of the stockhold-
ers." 222 Even board decisions to enact defensive tactics generally are
given the benefit of the presumption.22 Despite the traditional defer-
ence granted boards of directors under the business judgment rule,
courts now carefully scrutinize the adoption of certain antitakeover
measures for impermissible board activity.224
214. Id. at 14.
215. See supra notes 152-54 and accompanying text.
216. See supra notes 180-91 and accompanying text.
217. Wis. STAT. ANN. § 180.155 (West Supp. 1988). But see P.D. Smith & Co. v. Preway, Inc.,
644 F. Supp. 868 (W.D. Wis. 1986) (concluding that discriminatory poison pill unlawful under
Wisconsin law).
218. OHIo REv. CODE ANN. § 1701.16 (Anderson Supp. 1987).
219. See generally STATE TAKEOVER STATUTES, supra note 1, at 934-36.
220. See, e.g., Panter v. Marshall Field & Co., 646 F.2d 271, 293-95 (7th Cir. 1981); Auerbach
v. Bennett, 47 N.Y.2d 619, 629, 393 N.E.2d 994, 1000, 419 N.Y.S.2d 920, 926 (1979); see also Block
& Prussin, The Business Judgment Rule and Shareholder Derivative Actions: Viva Zapata, 37
Bus. LAW. 27 (1981).
221. By establishing a rebuttable presumption of validity, the business judgment rule pro-
tects corporate directors from liability based on judgments made in the ordinary management of
the corporation. Aronson v. Lewis, 473 A.2d 805, 813 (Del. 1984).
222. The presumption only applies if the actions are made in good faith by a disinterested
board of directors after reasonable inquiry into the best interests of the corporation and its share-
holders. Id. at 812-13.
223. See infra notes 225-61 and accompanying text.
224. If a plaintiff can show that the board of directors' "sole or primary motive" in using an
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In Unocal Corp. v. Mesa Petroleum Co.2 5 the Delaware Supreme
Court followed the general principle that the business judgment rule
protects a board of directors that institutes an antitakeover defense
without shareholder approval.2 26 Although a poison pill plan was not at
issue in Unocal, the case is important because it imposed on the Unocal
board227 the initial burden of proving the reasonableness of its decision
to oppose a takeover bid. 2 8 Under Unocal, a board of directors must
establish that it had "reasonable grounds for believing that a danger to
corporate policy and effectiveness existed. 2 2 9 The board can satisfy this
burden by demonstrating "good faith and reasonable investigation." 30
In addition the board must show that the defensive measure adopted
was "reasonable in relation to the threat posed."' 23 1 In determining the
reasonableness of its decision, the board may consider interests other
than the maximization of shareholder wealth. 2  Once the board satis-
fies this initial burden, the burden then shifts back to the plaintiff to
prove a breach by the board of its fiduciary duties..23  Thus, the Unocal
antitakeover tactic was to retain control of the company, the board loses its presumption of valid-
ity under the business judgment rule. See, e.g., Minstar, 621 F. Supp. at 1261.
225. 493 A.2d 946 (Del. 1985).
226. Id. at 954. The court concluded:
when a board addresses a pending takeover bid it has an obligation to determine whether the
offer is in the best interests of the corporation and its shareholders. In that respect a board's
duty is no different from any other responsibility it shoulders, and its decisions should be no
less entitled to the respect they otherwise would be accorded in the realm of business
judgment.
Id.
227. Mesa Petroleum, a 13% shareholder of Unocal stock, launched a takeover fight against
Unocal. Unocal responded by proposing a discriminatory exchange offer to all Unocal shareholders
except Mesa. Id. at 951.
228. Id. at 955. The court noted:
There are, however, certain caveats to a proper exercise of this function. Because of the omni-
present specter that a board may be acting primarily in its own interests, rather than those of
the corporation and its shareholders, there is an enhanced duty which calls for judicial exami-
nation of the threshold before the protections of the business judgment rule may be
conferred.
Id. at 954.
229. Id. at 955. This has been interpreted broadly to include threats to legitimate corporate
and stockholder interests. See AC Acquisitions Corp. v. Anderson, Clayton & Co., 519 A.2d 103,
111 (Del. Ch. 1986).
230. Id. (quoting Cheff v. Mathes, 199 A.2d 548, 555 (Del. 1964)); see also Smith v. Van
Gorkom, 488 A.2d 858 (Del. 1985).
231. Unocal, 493 A.2d at 955.
232. Id.
233. Id. at 958. The court stated:
Thus, unless it is shown by a preponderance of the evidence that the directors' decisions were
primarily based on perpetuating themselves in office, or some other breach of fiduciary duty
such as fraud, overreaching, lack of good faith, or being uninformed, a Court will not substi-
tute its judgment for that of the board.
Id.
SHAREHOLDER RIGHTS PLANS
court modified the traditional business judgment rule and extended its
protection in the hostile takeover context to a board of directors which
can satisfy the initial burden of proof.2"4 By allowing a court to examine
the reasonableness of a board's adoption of a defensive tactic, Unocal
cleared the way for judicial intervention in takeover cases.
The Delaware Supreme Court applied the Unocal business judg-
ment rule approach to the adoption of a poison pill plan in Moran. In
Moran the Household board of directors, which consisted of a majority
of outside, independent directors,28 5 adopted a poison pill plan to ward
off potential hostile bidders.2's Household's plan consisted of a distribu-
tion of rights that became exercisable when an individual or an entity
acquired twenty percent of the company's stock, or when a tender offer
was made for thirty percent of the stock.23 7 The plan contained only a
flip-over provision, and Household could redeem the rights at any time
prior to the occurrence of one of the triggering events.23 8 Concluding
that the adoption of the poison pill plan was within the authority of the
board of directors, the court then focused its attention on the applica-
tion of the business judgment rule in the hostile takeover context.23 9
The Moran court applied the same standards for the business judg-
ment rule established in Unocal and required the Household board of
directors to satisfy the initial burden of proof.2 40 The court noted that
the board's ability to satisfy this burden was enhanced materially be-
cause a majority of the board of directors consisted of outside, indepen-
dent directors. 241 The Household directors had to show that they had
reasonable grounds for believing a danger to the corporation existed
and that the defensive mechanism adopted was reasonable in relation
to the threat posed.24 2 Generally, a court only will apply the protection
of the business judgment rule after the directors have satisfied burden
of proof. Once a court applies the business judgment rule, however, the
burden of proof shifts back to the plaintiffs to demonstrate that the
board of directors has acted either in bad faith, or for purposes of
entrenchment.2 43
234. Id. at 957.
235. Moran, 500 A.2d at 1356.
236. Id. at 1349. This plan was enacted solely as a preventative measure.
237. Id. at 1348.
238. Id. at 1349.
239. Id. at 1355. Moran, the largest single shareholder of Household stock, attacked the plan
on the ground that the Household board of directors was not authorized to adopt the plan. Id. at
1351.
240. Id. at 1346.
241. Id. at 1356.
242. Id. (stating that "when the business judgment rule applies to the adoption of a defen-
sive mechanism, the initial burden will lie with the directors").
243. Id. (noting that the plaintiffs have the "ultimate burden of persuasion to show a breach
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The Moran court held that the Household board of directors was
entitled to the protection of the business judgment rule in its adoption
of the shareholder rights plan because it had satisfied its burden of
proof.244 The board demonstrated that the directors had a good faith
belief in the necessity of the plan to protect the company from coercive
takeover tactics and that the plan was reasonable in relation to the
threat posed.245 Because the plaintiffs were unable to prove that the
Household board acted in bad faith, or for the purpose of entrench-
ment, the court upheld the adoption of the shareholder rights plan.24 6
Emphasizing the prospective nature of the board's decisions, the
Moran court implied that the directors' initial burden of proof might be
less rigorous if the board adopts a poison pill plan in advance of a con-
tested takeover. 47 On the other hand, a reactive decision, adopted to
oppose a specific threat may increase the initial burden of proof. 248 By
lessening the directors' burden of proof for a plan adopted in advance
of a takeover bid, the Moran court weakened the Unocal test.249
In Dynamics Corp. of America v. CTS Corp.260 the Seventh Circuit
Court of Appeals more clearly specified the "good faith and reasonable
investigation" test adopted in Unocal.251 The court of appeals' ap-
proach was twofold: first, the court analyzed the role of the indepen-
dent advisor;252 and second, the court directed increased scrutiny of the
actual terms of the poison pill plan.2 3 The court of appeals remanded
the case for further in-depth analysis because the court recognized the
potential conflict between the interests of shareholders and the inter-
ests of the board of directors. 5' Both the district court and the court of
of the directors' fiduciary duties").
244. Id. at 1357.
245. Id. at 1356-57 (citing Smith v. Van Gorkom, 488 A.2d 858, 873 (Del. 1985), and conclud-
ing the Household board had made an informed decision after reasonable investigation).
246. Id. at 1357.
247. Id. at 1350 (stating that "pre-planning for the contingency of a hostile takeover might
reduce the risk that, under the pressure of a takeover bid, management will fail to exercise reason-
able judgment").
248. Id. (noting that "in reviewing a pre-planned defensive mechanism it seems even more
appropriate to apply the business judgment rule").
249. See Unocal, 493 A.2d at 949. Unocal requires that the defensive measure be reasonable
in relation to the threat posed. Id. The adoption of an extreme defensive tactic like the poison pill
by a board responding to potential or remote threats probably would fail under Unocal but is
encouraged by Moran.
250. 805 F.2d 705 (7th Cir. 1986).
251. Id. at 717.
252. Id. at 710. The independent advisor was Smith Barney.
253. Id. at 712. The court also questioned the valuation of CTS stock under the poison pill
plan. Id. at 713.
254. Veasey, The New Incarnation of the Business Judgment Rule in Takeover Defenses, 11
DEL. J. CORP. L. 503 (1986). Veasey states that "[s]ince a successful defense to a takeover will
inevitably result in a continuation of the board in control, the motives of the board became an
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appeals favored protecting the shareholders' interests over those of the
board of directors. The two opinions held that the decision by the
board of directors to adopt a poison pill plan had to be reviewed care-
fully in order to ensure that the plan was protecting the shareholders'
interest in wealth maximization, instead of the board's interest in main-
taining control of the company."5
Thus, with respect to contests for corporate control, courts judging
the adequacy of particular poison pill plans have signaled that they first
will protect the shareholders' goal of wealth maximization. A board of
directors, therefore, must realize that the adoption of a particular
poison pill plan will be subject to enhanced judicial review under a
modified business judgment rule. In order to survive this heightened
scrutiny, a board of directors' decision to adopt a poison pill plan must
be supported by evidence of careful consideration of alternative defen-
sive tactics and by proof that the plan will protect and maximize share-
holder wealth.
When reviewing a board's decision to adopt a poison pill plan a
court utilizing the modified business judgment rule will consider several
factors. First, the timing of the implementation of the takeover device.
A prospective adoption of a poison pill plan, such as the one in Mo-
ran,256 will be viewed more favorably than a reactive implementation of
the exact same plan. Second, the independence of outside counsel and
directors. An outside advisor or director must be truly independent and
have a minimal financial interest in the outcome of a plan.257 Third, the
fairness of the terms of the poison pill plan.2 58 The board must intro-
duce evidence to demonstrate the reasonableness of the trigger percent-
age and the trigger price. 59 A court will review the calculation of the
issue." Id. at 508. In essence, the underlying conflict is a clash of fundamental interests within the
corporate structure: the right of shareholders to receive and consider tender offers in order to
maximize their wealth, on the one hand; and the desire of a board of directors to limit takeovers in
order to maintain controls, on the other. The conflict is more apparent when a board of directors
rejects a tender offer for a fair price because the tender offeror is hostile to the board and might be
expected to replace the target's board members.
255. Dynamics, 805 F.2d at 708, aff'g, 635 F. Supp. 1174, 1178-80 (N.D. Ill. 1986).
256. See supra notes 235-49 and accompanying text.
257. Dynamics, 805 F.2d at 711.
258. The result of the plan must not be to prevent all tender offers. Evidence must be
presented to show that the trigger percentage set by the board has a reasonable base, one which
would give a minority shareholder blocking power. Id. at 712. "Blocking power" is the ability of a
shareholder to obstruct a decision made by the board of directors. This power may exist where a
large block of shares, even though a minority, is owned by one group and the remaining shares are
widely scattered. See Gottesman v. General Motors Corp., 279 F. Supp. 361, 368 (S.D.N.Y. 1967),
aff'd, 436 F.2d 1205 (2d Cir.), cert. denied, 403 U.S. 911 (1971).
259. The methods of valuating the price of the stock must be clarified. Poison pill plans
usually deter tender offers at prices below the trigger price because the acquiror offers at one price,
but then is forced to buy out nontendering shareholders at the higher "poison pill" price. Dynam-
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trigger price and the selection of the trigger percentage, and if the price
is set unrealistically high or the percentage is too low, 260 the poison pill
plan will be invalidated.2 61 Finally, a court may look at the board's will-
ingness to negotiate and to act as an auctioneer when the company is
faced with a tender offer.
B. The Duty to Negotiate and the Role of The Board of Directors
as Auctioneers
Courts have begun to consider the idea that a board of directors
must act as an impartial auctioneer during a control contest. Once a
tender offer has begun and it becomes apparent that the acquisition or
the break-up of the company is inevitable, a board that has adopted a
poison pill plan may have a duty to negotiate with a hostile acquiror
and to act as an impartial auctioneer in order to receive the protection
of the business judgment rule.26 2 Although the effect of this require-
ment places a premium on the maximization of shareholder wealth, it
ultimately may weaken the ability of a board of directors to defend a
corporation from a hostile suitor.268
The idea first appeared in Justice Walsh's Delaware Chancery
Court opinion in the Revlon case.26 4 Enjoining the "lockup option," Jus-
tice Walsh wrote that, "[o]nce the breakup of Revlon became inevitable
.. .the board [had] to view its primary role as the promoter of bids,
with price the dominant consideration. '26 5 On appeal, the Delaware Su-
preme Court endorsed the theory that the directors' fiduciary obliga-
tions change when it becomes apparent that the sale of the company or
its parts is inevitable. 6 Under these circumstances, the board's role
ics, 805 F.2d at 716. If the poison pill price exceeds the maximum reasonable sale value of the
company, the poison pill plan may eliminate completely the market for corporate control. Id.
260. The court in Dynamics found that the trigger price could be considered unrealistic be-
cause of Dynamics' overly optimistic estimation of its expected earnings. The court stated that
"consistent failure to achieve or even approach forecasted performance is relevant evidence on the
realism of a company's methods of forecasting." Id. at 716.
261. Id. at 714. The trigger price is very important when deciding issues of reasonableness
and good faith because if set too high it will "prevent all tender offers, not just those that are
below the corporation's sale value." Id.
262. Oesterle, Target Managers, supra note 125, at 53.
263. See Bogen & Duke, The Auctioneer's Duty: Unraveling Revlon, 2 INSIGHTS, July 1988,
at 3 (pointing out that Revlon suggests a narrowly constrained role for directors, contrary to the
broad discretion typically afforded boards by the business judgment rule).
264. MacAndrews & Forbes Holdings, Inc. v. Revlon, Inc., 501 A.2d 1239 (Del. Ch. 1985)
(Walsh, J.), aff'd, 506 A.2d 173 (Del. 1986). Revlon had given a lockup option on its health divi-
sions to Forstmann Litte & Co. in the face of a hostile takeover attempt by Pantry Pride.
265. Id. at 1250-51.
266. Revlon, 506 A.2d at 182. The court stated that once the sale was inevitable, "[tihe duty
of the board had . . . changed from the preservation of Revlon as a corporate entity to the max-
imization of the company's value at a sale for the stockholders' benefit." Id.
204 [Vol. 42:173
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changes "from defenders of the corporate bastion to auctioneers
charged with getting the best price for the stockholders at a sale of the
company. 2 67 The Delaware Supreme Court concluded that the Revlon
board breached this duty when it granted to a friendly party an option
to purchase a division of the company at a price substantially below the
estimated market value.268
The Second Circuit Court of Appeals, interpreting New York law
in Hanson Trust PLC v. ML SCM Acquisition, Inc.,2 69 reached a con-
clusion similar to Revlon, but with more emphasis on scrutinizing the
procedures the board followed in deciding to grant a lockup option to
block a takeover by Hanson Trust.27 ° The Second Circuit concluded
that the lockup was approved without sufficient careful consideration. 7 '
The Hanson Trust court implicitly suggested that the directors should
have turned the matter over to a completely independent committee of
directors.72 Overall, the Second Circuit seemed more critical of specific
board conduct than the decisions the board had reached.
Courts are now moving beyond implicit pressures on target boards
to negotiate.273 In Edelman v. Fruehauf Corp.Y this new duty for take-
over defense was discussed explicitly. The Sixth Circuit Court of Ap-
peals, applying Michigan corporate law, enjoined a management
leveraged buyout that had been put together hastily to block a bid by
New York investor Asher Edelman. In keeping with Revlon and Han-
son Trust, the Sixth Circuit found that the board had breached its duty
to seek maximum value for its shareholders. However, the court also
took the highly unusual step of ordering the target's board to conduct
good faith negotiations with all potential offerors, including Edelman.2 7 1
In CRTF Corp. v. Federated Dep't Stores 27 the United States Dis-
trict Court for the Southern District of New York recognized the duty
267. Id. Defining the duty that a board owes to stockholders when a sale of the company
becomes inevitable, the court instructed:
[A] board may have regard for various constituencies in discharging its responsibilities, pro-
vided there are rationally related benefits accruing to the stockholders .... However, such
concern for nonstockholder interests is inappropriate when an auction among active bidders is
in progress, and the object no longer is to protect or maintain the corporate enterprise but to
sell it to the highest bidder.
Id.
268. Id. at 185.
269. 781 F.2d 264 (2d Cir. 1986).
270. Id. at 275-77.
271. Id. at 277.
272. Id. at 283 (citing Revlon, 501 A.2d at 1249).
273. See, e.g., In re Anderson, Clayton Shareholders' Litig., 519 A.2d 669 (Del. Ch. 1986).
274. 798 F.2d 882 (6th Cir. 1986).
275. Id. at 885.




of a board of directors, which has enacted a poison pill plan and which
is faced with a tender offer, to negotiate and to serve as an auctioneer of
the company.17 7 Following the reasoning in Revlon, the Federated court
stated that in an auction situation the directors are charged with a duty
of selling the company at the price that will maximize the stockholders'
profits .27 8 The court also recognized the duty of a target board to nego-
tiate and to "seek improvements in price and financing arrangements
and ... competing bids. ' 279 Refusing to enjoin the Federated poison
pill plan, the court concluded that a poison pill plan that does not con-
tain a price barrier 280 may assist the directors in complying with their
fiduciary duties to negotiate and to maximize shareholder wealth. 281 In
addition, the CRTF court observed that even during an auction, a
poison pill plan may benefit shareholders be deterring a street sweep or
front-end loaded offer by a bidder or third party that could otherwise
end the auction.2 82 Thus, a poison pill plan carefully structured with the
relevant cases in mind can withstand the scrutiny of the courts both in
the prospective and the reactive stage.
The Delaware Chancery Court in City Capital Associates v. In-
terco Inc.2"' clarified the duty to auction first announced in Revlon.284
Interco involved two questions: (1) whether Interco's board of directors
in refusing to redeem a poison pill plan was breaching their fiduciary
duties to stockholders under Unocal and Moran;28 5 and (2) whether the
implementation of a restructuring plan constituted a violation of the
board's fiduciary duty under Unocal and Revlon."6 The Interco court
concluded that the poison pill plan was not a reasonable response to the
threat to Interco from City Capital Associates' (CCA) noncoercive of-
fer.287 The court upheld the restructuring, however, on the theory that
277. Id. at 98,118-19.
278. Id. at 98,118 (quoting Revlon, 506 A.2d at 184 n.16).
279. Id. at 98,119.
280. A price barrier may discourage offers below a perhaps artificially high trigger price. See
Dynamics, 805 F.2d at 705.
281. CRTF Corp., [1987-1988 Transfer Binder] Fed. Sec. L. Rep. (CCH), at 98,120. Com-
menting on the duty of a board to negotiate and auction, the court stated that a poison pill plan
"provides the directors with a shield to fend off coercive offers and with a gavel to run an auction."
Id.
282. Id. The court remarked that a board of directors under Delaware law need not be a
"passive observer;" on the contrary, a board should use its powers to defeat a coercive offer where
it "believes the offer would not be in the best interest of the shareholders." Id.
283. C.A. No. 10105 (Del. Ch. Nov. 1, 1988).
284. See supra notes 264-68 and accompanying text.
285. Interco, C.A. No. 10105, slip op. at 1-2.
286. Id.
287. Id. at 4. The fact that CCA's offer was a cash offer for all shares, and thus noncoercive,
seemed to weigh heavily in the court's decision to enjoin Interco's pill. The Interco court ruled
that Unocal and Moran supply the appropriate legal framework for evaluating the adoption of a
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it constituted a reasonable response to an offering price perceived by
Interco's board to be "inadequate."2 8 8 Concluding that by implementing
the restructuring Interco's board had not breached any duties under
Unocal and Moran, Chancellor Allen proceeded to clarify the fiduciary
duties required by Revlon.289
CCA argued that the restructuring was in effect a sale and breakup
of the company, and, therefore, Interco's board had a duty under Rev-
Ion to sell the company, by means of an auction, to the highest bid-
der. 29 0 The court, however, rejected CCA's argument, concluding that
even when a company is clearly for sale a board of directors, if disinter-
ested, is obligated to exercise business judgment in pursuing the stock-
holders' interest.29 1 Chancellor Allen commented that Revlon should
not be read as requiring a board to "shop" or conduct an auction pro-
cess every time a merger agreement is signed. Instead, the duty of the
board is to act in an "informed manner," which would include probing
the market for the values of alternative transactions.292 Although the
court recognized that an auction or open contest may be the most relia-
ble source for maximizing shareholder wealth,293 it concluded that a
board can satisfy its fiduciary obligations in ways other than a tradi-
tional auction.294 In not specifying a uniform response that must be fol-
lowed in the hostile takeover context and in requiring that a board of
directors has a duty to react to a control contest in an informed manner
that is designed to maximize shareholder wealth, Interco seems to allow
a board to respond to a battle for corporate control with more latitude
than Revlon.
V. CONCLUSION
When evaluating poison pill plans, courts should utilize the modi-
fied business judgment rule developed in Unocal, Moran, and Dynam-
ics. Because a conflict of interest exists any time a board of directors
adopts a defensive measure in response to a takeover threat, courts
defensive tactic in the hostile takeover context. In addition, the court distinguished Ivanhoe Part-
ners v. Newmont Mining Corp., 535 A.2d 1334 (Del. 1987), which placed on the board of directors
the burden of proving the entire fairness of keeping a pill in place while implementing a recapitali-
zation, as only applying to situations where a board has engaged in self-dealing. Interco, C.A. No.
10105, slip op. at 3.
288. Id. at 4.
289. Id. at 37-44.
290. Id. at 38.
291. Id. at 39 (citing In re J.P. Stevens & Co., Inc. Shareholders Litig., 542 A.2d 770 (Del Ch.
1982); In re Fort Howard Corp. Shareholders Litig., C.A. No. 9991 (Del. Ch. Aug. 8, 1988); and
Mills Acquisition Co. v. Macmillan, Inc., C.A. No. 10168 (Del. Ch. Oct. 17, 1988)).
292. Interco, C.A. No. 10105, slip op. at 41.
293. Id. at 42.
294. Id. at 41.
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should reverse the traditional burden of proof under the business judg-
ment rule and place on the board the burden of proving the first two
prongs in the Unocal test. This approach will help to ensure that share-
holder wealth maximization remains the primary goal of all defensive
tactics. First, the board must prove the plan was adopted in good faith
and pursuant to a reasonable investigation into the existing damages.
Second, the board must show that its adoption of a poison pill plan was
reasonable in relation to the actual threat posed. Satisfying its burden
of proof under the first two prongs, the board should then be protected
by a presumption of sound business judgment, unless the opposing
party can demonstrate that the plan was enacted for purposes of en-
trenchment. Boards enacting prospective pills should be careful to
adopt their plans in accordance with the guidelines set forth in the de-
cisions regarding poison pills.
When faced with an actual tender offer the board should have a
duty to react in an informed manner to maximize shareholder wealth.
In some cases an auction may provide the highest price and be in the
best interests of shareholders; however, a disinterested board of direc-
tors should have some latitude in determining the method for achieving
these goals. If adopted with the proper guidelines in mind, a rights plan
may reinforce the underpinnings of our corporate laws rather than dis-
torting them by providing directors with greater time, opportunity, and
bargaining power to exercise their fiduciary responsibilities on behalf of
shareholders.
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